




Analysis Type:	PANTHER Overrepresentation Test (Released 20240807)
Annotation Version and Release Date:	PANTHER version 19.0 Released 2024-06-20
Analyzed List:	for.delta_af.windows.1percent.genenames.txt (Gallus gallus)
Reference List:	background_genes.fst.txt (Gallus gallus)
Test Type:	FISHER
Correction:	NONE
PANTHER GO-Slim Biological Process	background_genes.fst.txt - REFLIST (11890)	for.delta_af.windows.1percent.genenames.txt (262)	for.delta_af.windows.1percent.genenames.txt (expected)	for.delta_af.windows.1percent.genenames.txt (over/under)	for.delta_af.windows.1percent.genenames.txt (fold Enrichment)	for.delta_af.windows.1percent.genenames.txt (raw P-value)
lipid storage (GO:0019915)	3	3	.07	+	45.38	1.06E-05
regulation of complement activation (GO:0030449)	1	1	.02	+	45.38	2.20E-02
mitotic sister chromatid cohesion (GO:0007064)	8	4	.18	+	22.69	1.50E-05
retinol metabolic process (GO:0042572)	2	1	.04	+	22.69	4.36E-02
kinetochore assembly (GO:0051382)	6	2	.13	+	15.13	6.84E-03
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	3	1	.07	+	15.13	6.47E-02
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	6	2	.13	+	15.13	6.84E-03
negative regulation of innate immune response (GO:0045824)	3	1	.07	+	15.13	6.47E-02
mRNA splice site recognition (GO:0006376)	12	3	.26	+	11.35	2.01E-03
regulation of lymphocyte mediated immunity (GO:0002706)	4	1	.09	+	11.35	8.53E-02
regulation of leukocyte mediated immunity (GO:0002703)	4	1	.09	+	11.35	8.53E-02
regulation of chromatin organization (GO:1902275)	4	1	.09	+	11.35	8.53E-02
kinetochore organization (GO:0051383)	8	2	.18	+	11.35	1.24E-02
mRNA cis splicing, via spliceosome (GO:0045292)	4	1	.09	+	11.35	8.53E-02
complement activation (GO:0006956)	4	1	.09	+	11.35	8.53E-02
sister chromatid cohesion (GO:0007062)	16	4	.35	+	11.35	3.40E-04
outer dynein arm assembly (GO:0036158)	4	1	.09	+	11.35	8.53E-02
membrane protein ectodomain proteolysis (GO:0006509)	9	2	.20	+	10.08	1.57E-02
skeletal muscle tissue development (GO:0007519)	14	3	.31	+	9.72	3.22E-03
positive regulation of adenylate cyclase activity (GO:0045762)	5	1	.11	+	9.08	1.05E-01
regulation of meiotic cell cycle (GO:0051445)	10	2	.22	+	9.08	1.94E-02
purine nucleobase metabolic process (GO:0006144)	10	2	.22	+	9.08	1.94E-02
regulation of immune effector process (GO:0002697)	5	1	.11	+	9.08	1.05E-01
neuron projection extension (GO:1990138)	5	1	.11	+	9.08	1.05E-01
retinoid metabolic process (GO:0001523)	5	1	.11	+	9.08	1.05E-01
diterpenoid metabolic process (GO:0016101)	5	1	.11	+	9.08	1.05E-01
developmental cell growth (GO:0048588)	5	1	.11	+	9.08	1.05E-01
cell growth (GO:0016049)	5	1	.11	+	9.08	1.05E-01
developmental growth involved in morphogenesis (GO:0060560)	5	1	.11	+	9.08	1.05E-01
skeletal muscle organ development (GO:0060538)	16	3	.35	+	8.51	4.79E-03
IMP biosynthetic process (GO:0006188)	6	1	.13	+	7.56	1.25E-01
acidic amino acid transport (GO:0015800)	6	1	.13	+	7.56	1.25E-01
spliceosomal complex assembly (GO:0000245)	18	3	.40	+	7.56	6.76E-03
negative regulation of nuclear division (GO:0051784)	13	2	.29	+	6.98	3.21E-02
protein targeting to vacuole (GO:0006623)	13	2	.29	+	6.98	3.21E-02
muscle organ development (GO:0007517)	20	3	.44	+	6.81	9.14E-03
positive regulation of canonical Wnt signaling pathway (GO:0090263)	20	3	.44	+	6.81	9.14E-03
regulation of adenylate cyclase activity (GO:0045761)	7	1	.15	+	6.48	1.44E-01
hormone metabolic process (GO:0042445)	14	2	.31	+	6.48	3.70E-02
positive regulation of actin filament bundle assembly (GO:0032233)	7	1	.15	+	6.48	1.44E-01
membrane protein proteolysis (GO:0033619)	14	2	.31	+	6.48	3.70E-02
developmental growth (GO:0048589)	7	1	.15	+	6.48	1.44E-01
humoral immune response (GO:0006959)	7	1	.15	+	6.48	1.44E-01
protein K11-linked ubiquitination (GO:0070979)	7	1	.15	+	6.48	1.44E-01
growth (GO:0040007)	7	1	.15	+	6.48	1.44E-01
cell adhesion mediated by integrin (GO:0033627)	21	3	.46	+	6.48	1.05E-02
positive regulation of Wnt signaling pathway (GO:0030177)	23	3	.51	+	5.92	1.35E-02
receptor clustering (GO:0043113)	8	1	.18	+	5.67	1.63E-01
reticulophagy (GO:0061709)	8	1	.18	+	5.67	1.63E-01
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	33	4	.73	+	5.50	5.70E-03
positive regulation of cell development (GO:0010720)	33	4	.73	+	5.50	5.70E-03
integrin-mediated signaling pathway (GO:0007229)	25	3	.55	+	5.45	1.70E-02
maintenance of location (GO:0051235)	25	3	.55	+	5.45	1.70E-02
regulation of cell development (GO:0060284)	51	6	1.12	+	5.34	8.48E-04
activation of GTPase activity (GO:0090630)	35	4	.77	+	5.19	7.05E-03
positive regulation of cyclase activity (GO:0031281)	9	1	.20	+	5.04	1.82E-01
hemostasis (GO:0007599)	9	1	.20	+	5.04	1.82E-01
blood coagulation (GO:0007596)	9	1	.20	+	5.04	1.82E-01
terpenoid metabolic process (GO:0006721)	9	1	.20	+	5.04	1.82E-01
regulation of cell cycle G1/S phase transition (GO:1902806)	18	2	.40	+	5.04	5.87E-02
wound healing (GO:0042060)	18	2	.40	+	5.04	5.87E-02
positive regulation of lyase activity (GO:0051349)	9	1	.20	+	5.04	1.82E-01
nucleosome assembly (GO:0006334)	9	1	.20	+	5.04	1.82E-01
IMP metabolic process (GO:0046040)	9	1	.20	+	5.04	1.82E-01
coagulation (GO:0050817)	9	1	.20	+	5.04	1.82E-01
nuclear envelope organization (GO:0006998)	9	1	.20	+	5.04	1.82E-01
immune effector process (GO:0002252)	9	1	.20	+	5.04	1.82E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	18	2	.40	+	5.04	5.87E-02
regulation of BMP signaling pathway (GO:0030510)	27	3	.59	+	5.04	2.09E-02
aspartate transmembrane transport (GO:0015810)	9	1	.20	+	5.04	1.82E-01
negative regulation of cell cycle phase transition (GO:1901988)	46	5	1.01	+	4.93	3.28E-03
nucleobase metabolic process (GO:0009112)	19	2	.42	+	4.78	6.47E-02
regulation of Wnt signaling pathway (GO:0030111)	57	6	1.26	+	4.78	1.53E-03
positive regulation of GTPase activity (GO:0043547)	48	5	1.06	+	4.73	3.95E-03
negative regulation of Wnt signaling pathway (GO:0030178)	29	3	.64	+	4.69	2.53E-02
negative regulation of mitotic cell cycle phase transition (GO:1901991)	29	3	.64	+	4.69	2.53E-02
negative regulation of cell cycle process (GO:0010948)	49	5	1.08	+	4.63	4.32E-03
peptide catabolic process (GO:0043171)	10	1	.22	+	4.54	2.00E-01
cell-matrix adhesion (GO:0007160)	30	3	.66	+	4.54	2.77E-02
reciprocal meiotic recombination (GO:0007131)	20	2	.44	+	4.54	7.08E-02
regulation of actin filament bundle assembly (GO:0032231)	10	1	.22	+	4.54	2.00E-01
homologous recombination (GO:0035825)	20	2	.44	+	4.54	7.08E-02
positive regulation of synaptic transmission (GO:0050806)	20	2	.44	+	4.54	7.08E-02
protein export from nucleus (GO:0006611)	10	1	.22	+	4.54	2.00E-01
cilium movement involved in cell motility (GO:0060294)	10	1	.22	+	4.54	2.00E-01
endoplasmic reticulum tubular network organization (GO:0071786)	10	1	.22	+	4.54	2.00E-01
muscle tissue development (GO:0060537)	30	3	.66	+	4.54	2.77E-02
reciprocal homologous recombination (GO:0140527)	20	2	.44	+	4.54	7.08E-02
regulation of canonical Wnt signaling pathway (GO:0060828)	41	4	.90	+	4.43	1.23E-02
regulation of Rho protein signal transduction (GO:0035023)	21	2	.46	+	4.32	7.72E-02
negative regulation of BMP signaling pathway (GO:0030514)	21	2	.46	+	4.32	7.72E-02
protein-DNA complex assembly (GO:0065004)	32	3	.71	+	4.25	3.28E-02
Notch signaling pathway (GO:0007219)	22	2	.48	+	4.13	8.37E-02
cell-substrate adhesion (GO:0031589)	44	4	.97	+	4.13	1.57E-02
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	11	1	.24	+	4.13	2.17E-01
regulation of cell growth (GO:0001558)	11	1	.24	+	4.13	2.17E-01
positive regulation of cell-substrate adhesion (GO:0010811)	11	1	.24	+	4.13	2.17E-01
nucleosome organization (GO:0034728)	11	1	.24	+	4.13	2.17E-01
response to oxidative stress (GO:0006979)	22	2	.48	+	4.13	8.37E-02
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	22	2	.48	+	4.13	8.37E-02
endoplasmic reticulum organization (GO:0007029)	22	2	.48	+	4.13	8.37E-02
negative regulation of defense response (GO:0031348)	11	1	.24	+	4.13	2.17E-01
COPII-coated vesicle budding (GO:0090114)	11	1	.24	+	4.13	2.17E-01
axonemal dynein complex assembly (GO:0070286)	11	1	.24	+	4.13	2.17E-01
negative regulation of cell cycle (GO:0045786)	58	5	1.28	+	3.91	8.85E-03
regulation of neurogenesis (GO:0050767)	35	3	.77	+	3.89	4.12E-02
positive regulation of protein serine/threonine kinase activity (GO:0071902)	12	1	.26	+	3.78	2.35E-01
regulation of cyclase activity (GO:0031279)	12	1	.26	+	3.78	2.35E-01
C4-dicarboxylate transport (GO:0015740)	12	1	.26	+	3.78	2.35E-01
establishment of protein localization to vacuole (GO:0072666)	24	2	.53	+	3.78	9.73E-02
regulation of lyase activity (GO:0051339)	12	1	.26	+	3.78	2.35E-01
regulation of hormone levels (GO:0010817)	24	2	.53	+	3.78	9.73E-02
response to wounding (GO:0009611)	24	2	.53	+	3.78	9.73E-02
mitochondrial translation (GO:0032543)	12	1	.26	+	3.78	2.35E-01
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	12	1	.26	+	3.78	2.35E-01
negative regulation of mitotic cell cycle (GO:0045930)	37	3	.82	+	3.68	4.74E-02
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	25	2	.55	+	3.63	1.04E-01
meiosis I (GO:0007127)	25	2	.55	+	3.63	1.04E-01
purine ribonucleoside monophosphate metabolic process (GO:0009167)	13	1	.29	+	3.49	2.52E-01
respiratory electron transport chain (GO:0022904)	13	1	.29	+	3.49	2.52E-01
purine nucleoside monophosphate metabolic process (GO:0009126)	13	1	.29	+	3.49	2.52E-01
regulation of cell size (GO:0008361)	13	1	.29	+	3.49	2.52E-01
innate immune response (GO:0045087)	26	2	.57	+	3.49	1.11E-01
protein localization to vacuole (GO:0072665)	26	2	.57	+	3.49	1.11E-01
regulation of cell-substrate adhesion (GO:0010810)	13	1	.29	+	3.49	2.52E-01
L-alpha-amino acid transmembrane transport (GO:1902475)	13	1	.29	+	3.49	2.52E-01
positive regulation of cell differentiation (GO:0045597)	52	4	1.15	+	3.49	2.73E-02
meiosis I cell cycle process (GO:0061982)	27	2	.59	+	3.36	1.19E-01
synaptic vesicle endocytosis (GO:0048488)	27	2	.59	+	3.36	1.19E-01
positive regulation of hydrolase activity (GO:0051345)	68	5	1.50	+	3.34	1.69E-02
regulation of GTPase activity (GO:0043087)	69	5	1.52	+	3.29	1.79E-02
synaptic vesicle recycling (GO:0036465)	28	2	.62	+	3.24	1.26E-01
ribonucleoside monophosphate metabolic process (GO:0009161)	14	1	.31	+	3.24	2.68E-01
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	14	1	.31	+	3.24	2.68E-01
regulation of nuclear division (GO:0051783)	28	2	.62	+	3.24	1.26E-01
cilium or flagellum-dependent cell motility (GO:0001539)	14	1	.31	+	3.24	2.68E-01
regulation of body fluid levels (GO:0050878)	14	1	.31	+	3.24	2.68E-01
nucleus organization (GO:0006997)	14	1	.31	+	3.24	2.68E-01
cilium-dependent cell motility (GO:0060285)	14	1	.31	+	3.24	2.68E-01
defense response to symbiont (GO:0140546)	28	2	.62	+	3.24	1.26E-01
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051897)	14	1	.31	+	3.24	2.68E-01
extracellular matrix organization (GO:0030198)	100	7	2.20	+	3.18	6.54E-03
extracellular structure organization (GO:0043062)	100	7	2.20	+	3.18	6.54E-03
external encapsulating structure organization (GO:0045229)	100	7	2.20	+	3.18	6.54E-03
muscle structure development (GO:0061061)	58	4	1.28	+	3.13	3.87E-02
regulation of cellular response to growth factor stimulus (GO:0090287)	44	3	.97	+	3.09	7.24E-02
peptidyl-tyrosine dephosphorylation (GO:0035335)	15	1	.33	+	3.03	2.84E-01
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	15	1	.33	+	3.03	2.84E-01
negative regulation of RNA catabolic process (GO:1902369)	15	1	.33	+	3.03	2.84E-01
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	15	1	.33	+	3.03	2.84E-01
negative regulation of response to external stimulus (GO:0032102)	15	1	.33	+	3.03	2.84E-01
axoneme assembly (GO:0035082)	15	1	.33	+	3.03	2.84E-01
regulation of cell differentiation (GO:0045595)	91	6	2.01	+	2.99	1.52E-02
regulation of cell cycle phase transition (GO:1901987)	76	5	1.67	+	2.99	2.60E-02
regulation of nervous system development (GO:0051960)	48	3	1.06	+	2.84	8.88E-02
establishment or maintenance of bipolar cell polarity (GO:0061245)	16	1	.35	+	2.84	3.00E-01
electron transport chain (GO:0022900)	16	1	.35	+	2.84	3.00E-01
nucleoside monophosphate metabolic process (GO:0009123)	16	1	.35	+	2.84	3.00E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090)	16	1	.35	+	2.84	3.00E-01
microautophagy (GO:0016237)	16	1	.35	+	2.84	3.00E-01
regulation of mRNA splicing, via spliceosome (GO:0048024)	32	2	.71	+	2.84	1.56E-01
negative regulation of immune system process (GO:0002683)	16	1	.35	+	2.84	3.00E-01
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	16	1	.35	+	2.84	3.00E-01
piecemeal microautophagy of the nucleus (GO:0034727)	16	1	.35	+	2.84	3.00E-01
negative regulation of cell cycle G2/M phase transition (GO:1902750)	16	1	.35	+	2.84	3.00E-01
regulation of ERK1 and ERK2 cascade (GO:0070372)	16	1	.35	+	2.84	3.00E-01
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051896)	16	1	.35	+	2.84	3.00E-01
regulation of growth (GO:0040008)	16	1	.35	+	2.84	3.00E-01
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	16	1	.35	+	2.84	3.00E-01
GPI anchor biosynthetic process (GO:0006506)	16	1	.35	+	2.84	3.00E-01
establishment or maintenance of apical/basal cell polarity (GO:0035088)	16	1	.35	+	2.84	3.00E-01
dicarboxylic acid transport (GO:0006835)	16	1	.35	+	2.84	3.00E-01
L-amino acid transport (GO:0015807)	16	1	.35	+	2.84	3.00E-01
meiotic nuclear division (GO:0140013)	33	2	.73	+	2.75	1.64E-01
negative regulation of multicellular organismal process (GO:0051241)	33	2	.73	+	2.75	1.64E-01
defense response to other organism (GO:0098542)	33	2	.73	+	2.75	1.64E-01
isoprenoid metabolic process (GO:0006720)	17	1	.37	+	2.67	3.15E-01
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	17	1	.37	+	2.67	3.15E-01
protein localization to cell junction (GO:1902414)	17	1	.37	+	2.67	3.15E-01
intrinsic apoptotic signaling pathway (GO:0097193)	17	1	.37	+	2.67	3.15E-01
GPI anchor metabolic process (GO:0006505)	17	1	.37	+	2.67	3.15E-01
protein processing (GO:0016485)	53	3	1.17	+	2.57	1.11E-01
purine ribonucleotide catabolic process (GO:0009154)	18	1	.40	+	2.52	3.31E-01
intraciliary transport (GO:0042073)	18	1	.40	+	2.52	3.31E-01
regulation of mitotic cell cycle phase transition (GO:1901990)	54	3	1.19	+	2.52	1.16E-01
regulation of mRNA processing (GO:0050684)	37	2	.82	+	2.45	1.96E-01
cell cycle checkpoint signaling (GO:0000075)	37	2	.82	+	2.45	1.96E-01
positive regulation of developmental process (GO:0051094)	75	4	1.65	+	2.42	8.34E-02
chromosome organization (GO:0051276)	113	6	2.49	+	2.41	3.87E-02
purine nucleotide catabolic process (GO:0006195)	19	1	.42	+	2.39	3.45E-01
establishment of protein localization to extracellular region (GO:0035592)	19	1	.42	+	2.39	3.45E-01
protein secretion (GO:0009306)	19	1	.42	+	2.39	3.45E-01
cilium movement (GO:0003341)	19	1	.42	+	2.39	3.45E-01
release of sequestered calcium ion into cytosol (GO:0051209)	19	1	.42	+	2.39	3.45E-01
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	19	1	.42	+	2.39	3.45E-01
protein localization to extracellular region (GO:0071692)	19	1	.42	+	2.39	3.45E-01
positive regulation of catalytic activity (GO:0043085)	153	8	3.37	+	2.37	2.00E-02
DNA recombination (GO:0006310)	77	4	1.70	+	2.36	8.99E-02
protein-DNA complex organization (GO:0071824)	118	6	2.60	+	2.31	4.62E-02
protein O-linked glycosylation (GO:0006493)	40	2	.88	+	2.27	2.20E-01
heterochromatin formation (GO:0031507)	20	1	.44	+	2.27	3.60E-01
regulation of MAP kinase activity (GO:0043405)	20	1	.44	+	2.27	3.60E-01
striated muscle contraction (GO:0006941)	20	1	.44	+	2.27	3.60E-01
ribonucleotide catabolic process (GO:0009261)	20	1	.44	+	2.27	3.60E-01
microtubule-based movement (GO:0007018)	100	5	2.20	+	2.27	6.99E-02
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	62	3	1.37	+	2.20	1.56E-01
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	21	1	.46	+	2.16	3.74E-01
positive regulation of cell adhesion (GO:0045785)	21	1	.46	+	2.16	3.74E-01
regulation of angiogenesis (GO:0045765)	21	1	.46	+	2.16	3.74E-01
acetylcholine receptor signaling pathway (GO:0095500)	21	1	.46	+	2.16	3.74E-01
regulation of small GTPase mediated signal transduction (GO:0051056)	42	2	.93	+	2.16	2.36E-01
regulation of cell cycle process (GO:0010564)	105	5	2.31	+	2.16	8.22E-02
regulation of vasculature development (GO:1901342)	21	1	.46	+	2.16	3.74E-01
negative regulation of sequestering of calcium ion (GO:0051283)	21	1	.46	+	2.16	3.74E-01
positive regulation of neurogenesis (GO:0050769)	21	1	.46	+	2.16	3.74E-01
positive regulation of cell communication (GO:0010647)	191	9	4.21	+	2.14	3.94E-02
positive regulation of signaling (GO:0023056)	191	9	4.21	+	2.14	3.94E-02
meiotic cell cycle process (GO:1903046)	43	2	.95	+	2.11	2.45E-01
response to external biotic stimulus (GO:0043207)	43	2	.95	+	2.11	2.45E-01
response to other organism (GO:0051707)	43	2	.95	+	2.11	2.45E-01
positive regulation of cellular component biogenesis (GO:0044089)	43	2	.95	+	2.11	2.45E-01
microtubule bundle formation (GO:0001578)	22	1	.48	+	2.06	3.88E-01
positive regulation of canonical NF-kappaB signal transduction (GO:0043123)	22	1	.48	+	2.06	3.88E-01
transcription initiation at RNA polymerase II promoter (GO:0006367)	22	1	.48	+	2.06	3.88E-01
response to biotic stimulus (GO:0009607)	44	2	.97	+	2.06	2.53E-01
biological process involved in interspecies interaction between organisms (GO:0044419)	44	2	.97	+	2.06	2.53E-01
protein-RNA complex assembly (GO:0022618)	67	3	1.48	+	2.03	1.83E-01
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	90	4	1.98	+	2.02	1.37E-01
regulation of multicellular organismal development (GO:2000026)	91	4	2.01	+	1.99	1.41E-01
regulation of developmental process (GO:0050793)	183	8	4.03	+	1.98	6.61E-02
potassium ion transmembrane transport (GO:0071805)	92	4	2.03	+	1.97	1.45E-01
regulation of cell cycle G2/M phase transition (GO:1902749)	23	1	.51	+	1.97	4.01E-01
positive regulation of molecular function (GO:0044093)	184	8	4.05	+	1.97	6.71E-02
potassium ion transport (GO:0006813)	92	4	2.03	+	1.97	1.45E-01
DNA repair (GO:0006281)	163	7	3.59	+	1.95	9.48E-02
regulation of hydrolase activity (GO:0051336)	118	5	2.60	+	1.92	1.91E-01
protein-RNA complex organization (GO:0071826)	71	3	1.56	+	1.92	2.06E-01
cellular response to fibroblast growth factor stimulus (GO:0044344)	24	1	.53	+	1.89	4.14E-01
positive regulation of organelle organization (GO:0010638)	48	2	1.06	+	1.89	2.86E-01
heterochromatin organization (GO:0070828)	24	1	.53	+	1.89	4.14E-01
hormone-mediated signaling pathway (GO:0009755)	24	1	.53	+	1.89	4.14E-01
regulation of innate immune response (GO:0045088)	24	1	.53	+	1.89	4.14E-01
fibroblast growth factor receptor signaling pathway (GO:0008543)	24	1	.53	+	1.89	4.14E-01
purine-containing compound catabolic process (GO:0072523)	24	1	.53	+	1.89	4.14E-01
response to fibroblast growth factor (GO:0071774)	24	1	.53	+	1.89	4.14E-01
cellular response to starvation (GO:0009267)	24	1	.53	+	1.89	4.14E-01
positive regulation of signal transduction (GO:0009967)	169	7	3.72	+	1.88	1.03E-01
synaptic vesicle cycle (GO:0099504)	49	2	1.08	+	1.85	2.94E-01
vesicle-mediated transport in synapse (GO:0099003)	49	2	1.08	+	1.85	2.94E-01
cell adhesion (GO:0007155)	221	9	4.87	+	1.85	6.30E-02
nucleotide catabolic process (GO:0009166)	25	1	.55	+	1.82	4.27E-01
phosphatidylinositol dephosphorylation (GO:0046856)	25	1	.55	+	1.82	4.27E-01
mitochondrial gene expression (GO:0140053)	25	1	.55	+	1.82	4.27E-01
chromatin organization (GO:0006325)	100	4	2.20	+	1.82	2.86E-01
glycosylation (GO:0070085)	100	4	2.20	+	1.82	2.86E-01
regulation of sequestering of calcium ion (GO:0051282)	25	1	.55	+	1.82	4.27E-01
vesicle budding from membrane (GO:0006900)	25	1	.55	+	1.82	4.27E-01
cellular response to nutrient levels (GO:0031669)	25	1	.55	+	1.82	4.27E-01
cellular response to extracellular stimulus (GO:0031668)	25	1	.55	+	1.82	4.27E-01
cell cycle process (GO:0022402)	226	9	4.98	+	1.81	1.01E-01
cell-cell adhesion (GO:0098609)	152	6	3.35	+	1.79	1.53E-01
transport along microtubule (GO:0010970)	51	2	1.12	+	1.78	3.10E-01
meiotic cell cycle (GO:0051321)	51	2	1.12	+	1.78	3.10E-01
negative regulation of organelle organization (GO:0010639)	52	2	1.15	+	1.75	3.18E-01
protein-containing complex localization (GO:0031503)	52	2	1.15	+	1.75	3.18E-01
mRNA destabilization (GO:0061157)	26	1	.57	+	1.75	4.40E-01
non-canonical Wnt signaling pathway (GO:0035567)	26	1	.57	+	1.75	4.40E-01
cellular response to external stimulus (GO:0071496)	26	1	.57	+	1.75	4.40E-01
regulation of response to biotic stimulus (GO:0002831)	26	1	.57	+	1.75	4.40E-01
negative regulation of gene expression, epigenetic (GO:0045814)	26	1	.57	+	1.75	4.40E-01
RNA destabilization (GO:0050779)	26	1	.57	+	1.75	4.40E-01
protein-containing complex assembly (GO:0065003)	184	7	4.05	+	1.73	1.29E-01
chemical synaptic transmission (GO:0007268)	132	5	2.91	+	1.72	2.19E-01
anterograde trans-synaptic signaling (GO:0098916)	132	5	2.91	+	1.72	2.19E-01
microtubule-based transport (GO:0099111)	53	2	1.17	+	1.71	3.27E-01
trans-synaptic signaling (GO:0099537)	133	5	2.93	+	1.71	2.21E-01
DNA metabolic process (GO:0006259)	240	9	5.29	+	1.70	1.14E-01
recombinational repair (GO:0000725)	54	2	1.19	+	1.68	3.35E-01
double-strand break repair via homologous recombination (GO:0000724)	54	2	1.19	+	1.68	3.35E-01
positive regulation of protein kinase activity (GO:0045860)	27	1	.59	+	1.68	4.52E-01
regulation of mitotic cell cycle (GO:0007346)	81	3	1.78	+	1.68	2.64E-01
macroautophagy (GO:0016236)	55	2	1.21	+	1.65	3.43E-01
immune response (GO:0006955)	55	2	1.21	+	1.65	3.43E-01
lipid localization (GO:0010876)	83	3	1.83	+	1.64	4.33E-01
cell cycle (GO:0007049)	250	9	5.51	+	1.63	1.26E-01
peptide metabolic process (GO:0006518)	167	6	3.68	+	1.63	1.87E-01
regulation of cell shape (GO:0008360)	28	1	.62	+	1.62	4.65E-01
translational initiation (GO:0006413)	28	1	.62	+	1.62	4.65E-01
alcohol metabolic process (GO:0006066)	56	2	1.23	+	1.62	3.51E-01
calcium ion transmembrane import into cytosol (GO:0097553)	28	1	.62	+	1.62	4.65E-01
regulatory ncRNA-mediated gene silencing (GO:0031047)	28	1	.62	+	1.62	4.65E-01
synaptic signaling (GO:0099536)	142	5	3.13	+	1.60	2.46E-01
cytoskeleton-dependent intracellular transport (GO:0030705)	57	2	1.26	+	1.59	3.59E-01
defense response (GO:0006952)	57	2	1.26	+	1.59	3.59E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	57	2	1.26	+	1.59	3.59E-01
regulation of cell cycle (GO:0051726)	143	5	3.15	+	1.59	2.49E-01
negative regulation of response to stimulus (GO:0048585)	172	6	3.79	+	1.58	2.84E-01
calcium ion transmembrane transport (GO:0070588)	58	2	1.28	+	1.56	3.67E-01
potassium ion import across plasma membrane (GO:1990573)	29	1	.64	+	1.56	4.76E-01
regulation of RNA splicing (GO:0043484)	58	2	1.28	+	1.56	3.67E-01
positive regulation of mRNA catabolic process (GO:0061014)	29	1	.64	+	1.56	4.76E-01
glycolipid biosynthetic process (GO:0009247)	29	1	.64	+	1.56	4.76E-01
cytoskeleton-dependent cytokinesis (GO:0061640)	29	1	.64	+	1.56	4.76E-01
negative regulation of cellular catabolic process (GO:0031330)	29	1	.64	+	1.56	4.76E-01
apoptotic signaling pathway (GO:0097190)	29	1	.64	+	1.56	4.76E-01
DNA damage response (GO:0006974)	203	7	4.47	+	1.56	2.21E-01
regulation of catalytic activity (GO:0050790)	262	9	5.77	+	1.56	1.94E-01
positive regulation of response to stimulus (GO:0048584)	234	8	5.16	+	1.55	1.79E-01
endocytosis (GO:0006897)	117	4	2.58	+	1.55	3.31E-01
negative regulation of protein metabolic process (GO:0051248)	88	3	1.94	+	1.55	4.46E-01
regulation of signal transduction (GO:0009966)	441	15	9.72	+	1.54	9.51E-02
regulation of immune response (GO:0050776)	59	2	1.30	+	1.54	3.75E-01
regulation of mRNA metabolic process (GO:1903311)	89	3	1.96	+	1.53	4.49E-01
response to stress (GO:0006950)	446	15	9.83	+	1.53	9.79E-02
regulation of chromosome organization (GO:0033044)	30	1	.66	+	1.51	4.88E-01
positive regulation of nervous system development (GO:0051962)	30	1	.66	+	1.51	4.88E-01
protein targeting to membrane (GO:0006612)	30	1	.66	+	1.51	4.88E-01
cytokinesis (GO:0000910)	30	1	.66	+	1.51	4.88E-01
regulation of cell communication (GO:0010646)	513	17	11.30	+	1.50	8.89E-02
negative regulation of signal transduction (GO:0009968)	151	5	3.33	+	1.50	3.91E-01
membrane organization (GO:0061024)	152	5	3.35	+	1.49	3.92E-01
regulation of signaling (GO:0023051)	517	17	11.39	+	1.49	9.10E-02
calcium ion homeostasis (GO:0055074)	61	2	1.34	+	1.49	3.90E-01
vacuolar transport (GO:0007034)	61	2	1.34	+	1.49	3.90E-01
mRNA splicing, via spliceosome (GO:0000398)	92	3	2.03	+	1.48	4.58E-01
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	92	3	2.03	+	1.48	4.58E-01
RNA splicing, via transesterification reactions (GO:0000375)	92	3	2.03	+	1.48	4.58E-01
regulation of response to stimulus (GO:0048583)	523	17	11.52	+	1.48	9.45E-02
purine ribonucleotide biosynthetic process (GO:0009152)	31	1	.68	+	1.46	4.99E-01
negative regulation of protein kinase activity (GO:0006469)	31	1	.68	+	1.46	4.99E-01
regulation of canonical NF-kappaB signal transduction (GO:0043122)	31	1	.68	+	1.46	4.99E-01
chromatin remodeling (GO:0006338)	93	3	2.05	+	1.46	4.62E-01
positive regulation of apoptotic process (GO:0043065)	31	1	.68	+	1.46	4.99E-01
muscle contraction (GO:0006936)	31	1	.68	+	1.46	4.99E-01
response to starvation (GO:0042594)	31	1	.68	+	1.46	4.99E-01
inorganic ion homeostasis (GO:0098771)	94	3	2.07	+	1.45	4.65E-01
negative regulation of cell communication (GO:0010648)	157	5	3.46	+	1.45	4.01E-01
negative regulation of signaling (GO:0023057)	157	5	3.46	+	1.45	4.01E-01
protein-containing complex organization (GO:0043933)	314	10	6.92	+	1.45	2.37E-01
negative regulation of cellular component organization (GO:0051129)	63	2	1.39	+	1.44	4.06E-01
cellular response to hormone stimulus (GO:0032870)	63	2	1.39	+	1.44	4.06E-01
ubiquitin-dependent protein catabolic process (GO:0006511)	191	6	4.21	+	1.43	3.19E-01
phospholipid dephosphorylation (GO:0046839)	32	1	.71	+	1.42	5.10E-01
muscle system process (GO:0003012)	32	1	.71	+	1.42	5.10E-01
positive regulation of programmed cell death (GO:0043068)	32	1	.71	+	1.42	5.10E-01
autophagy (GO:0006914)	64	2	1.41	+	1.42	6.53E-01
nucleoside phosphate catabolic process (GO:1901292)	32	1	.71	+	1.42	5.10E-01
process utilizing autophagic mechanism (GO:0061919)	64	2	1.41	+	1.42	6.53E-01
positive regulation of intracellular signal transduction (GO:1902533)	130	4	2.86	+	1.40	5.37E-01
protein targeting (GO:0006605)	65	2	1.43	+	1.40	6.55E-01
modification-dependent protein catabolic process (GO:0019941)	197	6	4.34	+	1.38	4.55E-01
purine ribonucleotide metabolic process (GO:0009150)	66	2	1.45	+	1.38	6.58E-01
negative regulation of protein phosphorylation (GO:0001933)	33	1	.73	+	1.38	5.21E-01
cellular respiration (GO:0045333)	33	1	.73	+	1.38	5.21E-01
non-membrane-bounded organelle assembly (GO:0140694)	99	3	2.18	+	1.38	4.82E-01
action potential (GO:0001508)	33	1	.73	+	1.38	5.21E-01
negative regulation of phosphorylation (GO:0042326)	33	1	.73	+	1.38	5.21E-01
chloride transmembrane transport (GO:1902476)	33	1	.73	+	1.38	5.21E-01
DNA-templated transcription initiation (GO:0006352)	33	1	.73	+	1.38	5.21E-01
purine-containing compound metabolic process (GO:0072521)	99	3	2.18	+	1.38	4.82E-01
epigenetic regulation of gene expression (GO:0040029)	33	1	.73	+	1.38	5.21E-01
regulation of defense response (GO:0031347)	33	1	.73	+	1.38	5.21E-01
modification-dependent macromolecule catabolic process (GO:0043632)	200	6	4.41	+	1.36	4.58E-01
protein maturation (GO:0051604)	167	5	3.68	+	1.36	4.21E-01
positive regulation of protein phosphorylation (GO:0001934)	67	2	1.48	+	1.35	6.60E-01
RNA splicing (GO:0008380)	102	3	2.25	+	1.33	4.93E-01
positive regulation of mRNA metabolic process (GO:1903313)	34	1	.75	+	1.33	5.32E-01
G protein-coupled receptor signaling pathway (GO:0007186)	238	7	5.24	+	1.33	3.72E-01
neuron development (GO:0048666)	205	6	4.52	+	1.33	4.64E-01
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	103	3	2.27	+	1.32	4.97E-01
inorganic cation transmembrane transport (GO:0098662)	206	6	4.54	+	1.32	4.66E-01
monoatomic cation transmembrane transport (GO:0098655)	206	6	4.54	+	1.32	4.66E-01
tissue development (GO:0009888)	138	4	3.04	+	1.32	5.50E-01
negative regulation of cellular process (GO:0048523)	693	20	15.27	+	1.31	2.28E-01
response to extracellular stimulus (GO:0009991)	35	1	.77	+	1.30	5.42E-01
response to nutrient levels (GO:0031667)	35	1	.77	+	1.30	5.42E-01
negative regulation of biological process (GO:0048519)	741	21	16.33	+	1.29	2.43E-01
nuclear division (GO:0000280)	71	2	1.56	+	1.28	6.71E-01
positive regulation of kinase activity (GO:0033674)	71	2	1.56	+	1.28	6.71E-01
calcium ion transport (GO:0006816)	71	2	1.56	+	1.28	6.71E-01
mitochondrial transmembrane transport (GO:1990542)	36	1	.79	+	1.26	5.52E-01
endomembrane system organization (GO:0010256)	108	3	2.38	+	1.26	5.16E-01
positive regulation of transferase activity (GO:0051347)	72	2	1.59	+	1.26	6.73E-01
autophagy of mitochondrion (GO:0000422)	36	1	.79	+	1.26	5.52E-01
glycolipid metabolic process (GO:0006664)	36	1	.79	+	1.26	5.52E-01
positive regulation of protein modification process (GO:0031401)	72	2	1.59	+	1.26	6.73E-01
ribonucleotide biosynthetic process (GO:0009260)	36	1	.79	+	1.26	5.52E-01
negative regulation of catabolic process (GO:0009895)	36	1	.79	+	1.26	5.52E-01
protein polyubiquitination (GO:0000209)	73	2	1.61	+	1.24	6.76E-01
ribonucleotide metabolic process (GO:0009259)	73	2	1.61	+	1.24	6.76E-01
negative regulation of phosphorus metabolic process (GO:0010563)	37	1	.82	+	1.23	5.62E-01
blood vessel development (GO:0001568)	37	1	.82	+	1.23	5.62E-01
cell division (GO:0051301)	37	1	.82	+	1.23	5.62E-01
negative regulation of phosphate metabolic process (GO:0045936)	37	1	.82	+	1.23	5.62E-01
liposaccharide metabolic process (GO:1903509)	37	1	.82	+	1.23	5.62E-01
sexual reproduction (GO:0019953)	74	2	1.63	+	1.23	6.79E-01
cellular response to stress (GO:0033554)	333	9	7.34	+	1.23	4.51E-01
chloride transport (GO:0006821)	37	1	.82	+	1.23	5.62E-01
import into cell (GO:0098657)	186	5	4.10	+	1.22	6.09E-01
proteolysis (GO:0006508)	373	10	8.22	+	1.22	4.73E-01
positive regulation of phosphorylation (GO:0042327)	112	3	2.47	+	1.22	7.39E-01
mRNA processing (GO:0006397)	113	3	2.49	+	1.20	7.40E-01
regulation of molecular function (GO:0065009)	339	9	7.47	+	1.20	5.70E-01
neuron projection development (GO:0031175)	189	5	4.16	+	1.20	6.13E-01
amide metabolic process (GO:0043603)	227	6	5.00	+	1.20	6.43E-01
vasculature development (GO:0001944)	38	1	.84	+	1.19	5.72E-01
neuron differentiation (GO:0030182)	268	7	5.91	+	1.19	6.70E-01
reproductive process (GO:0022414)	77	2	1.70	+	1.18	6.88E-01
organic hydroxy compound metabolic process (GO:1901615)	77	2	1.70	+	1.18	6.88E-01
reproduction (GO:0000003)	77	2	1.70	+	1.18	6.88E-01
cell-cell signaling (GO:0007267)	232	6	5.11	+	1.17	6.48E-01
positive regulation of phosphorus metabolic process (GO:0010562)	116	3	2.56	+	1.17	7.44E-01
positive regulation of phosphate metabolic process (GO:0045937)	116	3	2.56	+	1.17	7.44E-01
positive regulation of cellular process (GO:0048522)	813	21	17.91	+	1.17	4.56E-01
response to hormone (GO:0009725)	78	2	1.72	+	1.16	6.91E-01
regulation of trans-synaptic signaling (GO:0099177)	78	2	1.72	+	1.16	6.91E-01
ribose phosphate biosynthetic process (GO:0046390)	39	1	.86	+	1.16	5.81E-01
energy derivation by oxidation of organic compounds (GO:0015980)	39	1	.86	+	1.16	5.81E-01
modulation of chemical synaptic transmission (GO:0050804)	78	2	1.72	+	1.16	6.91E-01
monoatomic anion transmembrane transport (GO:0098656)	39	1	.86	+	1.16	5.81E-01
regulation of anatomical structure morphogenesis (GO:0022603)	78	2	1.72	+	1.16	6.91E-01
metal ion transport (GO:0030001)	237	6	5.22	+	1.15	6.53E-01
fatty acid metabolic process (GO:0006631)	79	2	1.74	+	1.15	6.94E-01
ribose phosphate metabolic process (GO:0019693)	79	2	1.74	+	1.15	6.94E-01
regulation of protein kinase activity (GO:0045859)	79	2	1.74	+	1.15	6.94E-01
inorganic ion transmembrane transport (GO:0098660)	239	6	5.27	+	1.14	6.55E-01
regulation of cell adhesion (GO:0030155)	40	1	.88	+	1.13	5.90E-01
generation of neurons (GO:0048699)	280	7	6.17	+	1.13	6.78E-01
DNA-templated transcription (GO:0006351)	80	2	1.76	+	1.13	6.97E-01
inorganic anion transmembrane transport (GO:0098661)	40	1	.88	+	1.13	5.90E-01
plasma membrane bounded cell projection organization (GO:0120036)	321	8	7.07	+	1.13	6.97E-01
cellular component organization (GO:0016043)	1576	39	34.73	+	1.12	4.08E-01
organelle fission (GO:0048285)	81	2	1.78	+	1.12	7.00E-01
regulation of protein phosphorylation (GO:0001932)	122	3	2.69	+	1.12	7.52E-01
mRNA metabolic process (GO:0016071)	163	4	3.59	+	1.11	7.84E-01
positive regulation of biological process (GO:0048518)	899	22	19.81	+	1.11	5.56E-01
cell projection organization (GO:0030030)	327	8	7.21	+	1.11	7.01E-01
regulation of kinase activity (GO:0043549)	123	3	2.71	+	1.11	7.53E-01
proteolysis involved in protein catabolic process (GO:0051603)	246	6	5.42	+	1.11	6.64E-01
activation of immune response (GO:0002253)	41	1	.90	+	1.11	6.00E-01
chromosome segregation (GO:0007059)	82	2	1.81	+	1.11	7.03E-01
nuclear-transcribed mRNA catabolic process (GO:0000956)	41	1	.90	+	1.11	6.00E-01
RNA biosynthetic process (GO:0032774)	82	2	1.81	+	1.11	7.03E-01
cilium organization (GO:0044782)	124	3	2.73	+	1.10	7.55E-01
cell morphogenesis involved in neuron differentiation (GO:0048667)	125	3	2.75	+	1.09	7.57E-01
monoatomic cation homeostasis (GO:0055080)	125	3	2.75	+	1.09	7.57E-01
regulation of phosphorylation (GO:0042325)	167	4	3.68	+	1.09	7.88E-01
regulation of transferase activity (GO:0051338)	126	3	2.78	+	1.08	7.58E-01
amino acid transmembrane transport (GO:0003333)	42	1	.93	+	1.08	6.08E-01
vesicle fusion (GO:0006906)	42	1	.93	+	1.08	6.08E-01
monoatomic cation transport (GO:0006812)	254	6	5.60	+	1.07	8.27E-01
protein catabolic process (GO:0030163)	256	6	5.64	+	1.06	8.28E-01
monoatomic ion homeostasis (GO:0050801)	128	3	2.82	+	1.06	7.61E-01
cellular component organization or biogenesis (GO:0071840)	1671	39	36.82	+	1.06	6.54E-01
monoatomic ion transmembrane transport (GO:0034220)	258	6	5.69	+	1.06	8.29E-01
negative regulation of protein modification process (GO:0031400)	43	1	.95	+	1.06	6.17E-01
organelle membrane fusion (GO:0090174)	43	1	.95	+	1.06	6.17E-01
mitochondrial transport (GO:0006839)	43	1	.95	+	1.06	6.17E-01
nucleic acid metabolic process (GO:0090304)	689	16	15.18	+	1.05	7.89E-01
organelle assembly (GO:0070925)	260	6	5.73	+	1.05	8.30E-01
neurogenesis (GO:0022008)	304	7	6.70	+	1.04	8.42E-01
nucleobase-containing compound metabolic process (GO:0006139)	830	19	18.29	+	1.04	8.07E-01
protein glycosylation (GO:0006486)	88	2	1.94	+	1.03	7.21E-01
mRNA catabolic process (GO:0006402)	44	1	.97	+	1.03	6.26E-01
organophosphate catabolic process (GO:0046434)	44	1	.97	+	1.03	6.26E-01
macromolecule glycosylation (GO:0043413)	88	2	1.94	+	1.03	7.21E-01
autophagosome assembly (GO:0000045)	44	1	.97	+	1.03	6.26E-01
animal organ morphogenesis (GO:0009887)	88	2	1.94	+	1.03	7.21E-01
monoatomic anion transport (GO:0006820)	44	1	.97	+	1.03	6.26E-01
Unclassified (UNCLASSIFIED)	4181	95	92.13	+	1.03	6.95E-01
biological regulation (GO:0065007)	3708	84	81.71	+	1.03	7.87E-01
regulation of multicellular organismal process (GO:0051239)	177	4	3.90	+	1.03	7.98E-01
cell morphogenesis (GO:0000902)	177	4	3.90	+	1.03	7.98E-01
purine nucleotide metabolic process (GO:0006163)	89	2	1.96	+	1.02	7.24E-01
nervous system development (GO:0007399)	403	9	8.88	+	1.01	8.63E-01
macromolecule catabolic process (GO:0009057)	314	7	6.92	+	1.01	8.47E-01
circulatory system development (GO:0072359)	90	2	1.98	+	1.01	1.00E00
phosphatidylinositol metabolic process (GO:0046488)	90	2	1.98	+	1.01	1.00E00
proteasomal protein catabolic process (GO:0010498)	136	3	3.00	+	1.00	1.00E00
regulation of phosphorus metabolic process (GO:0051174)	182	4	4.01	-	1.00	1.00E00
regulation of phosphate metabolic process (GO:0019220)	182	4	4.01	-	1.00	1.00E00
dephosphorylation (GO:0016311)	91	2	2.01	-	1.00	1.00E00
response to stimulus (GO:0050896)	1550	34	34.15	-	1.00	1.00E00
organonitrogen compound catabolic process (GO:1901565)	365	8	8.04	-	.99	1.00E00
heterocycle metabolic process (GO:0046483)	872	19	19.21	-	.99	1.00E00
positive regulation of cellular component organization (GO:0051130)	92	2	2.03	-	.99	1.00E00
organelle disassembly (GO:1903008)	46	1	1.01	-	.99	1.00E00
purine nucleotide biosynthetic process (GO:0006164)	46	1	1.01	-	.99	1.00E00
protein folding (GO:0006457)	92	2	2.03	-	.99	1.00E00
nucleobase-containing compound catabolic process (GO:0034655)	92	2	2.03	-	.99	1.00E00
positive regulation of cellular catabolic process (GO:0031331)	46	1	1.01	-	.99	1.00E00
biological_process (GO:0008150)	7709	167	169.87	-	.98	6.95E-01
regulation of biological process (GO:0050789)	3509	76	77.32	-	.98	8.91E-01
cellular aromatic compound metabolic process (GO:0006725)	880	19	19.39	-	.98	1.00E00
response to external stimulus (GO:0009605)	139	3	3.06	-	.98	1.00E00
double-strand break repair (GO:0006302)	93	2	2.05	-	.98	1.00E00
anatomical structure development (GO:0048856)	885	19	19.50	-	.97	1.00E00
catabolic process (GO:0009056)	562	12	12.38	-	.97	1.00E00
nucleobase-containing small molecule metabolic process (GO:0055086)	141	3	3.11	-	.97	1.00E00
regulation of cellular process (GO:0050794)	3314	70	73.03	-	.96	7.28E-01
cellular nitrogen compound metabolic process (GO:0034641)	996	21	21.95	-	.96	9.10E-01
multicellular organism development (GO:0007275)	667	14	14.70	-	.95	1.00E00
regulation of protein modification process (GO:0031399)	143	3	3.15	-	.95	1.00E00
regulation of organelle organization (GO:0033043)	191	4	4.21	-	.95	1.00E00
organelle organization (GO:0006996)	957	20	21.09	-	.95	9.09E-01
regulation of protein serine/threonine kinase activity (GO:0071900)	48	1	1.06	-	.95	1.00E00
RNA catabolic process (GO:0006401)	48	1	1.06	-	.95	1.00E00
positive regulation of cell migration (GO:0030335)	48	1	1.06	-	.95	1.00E00
vesicle organization (GO:0016050)	96	2	2.12	-	.95	1.00E00
regulation of response to external stimulus (GO:0032101)	48	1	1.06	-	.95	1.00E00
organic cyclic compound metabolic process (GO:1901360)	919	19	20.25	-	.94	9.07E-01
regulation of immune system process (GO:0002682)	97	2	2.14	-	.94	1.00E00
cell surface receptor signaling pathway (GO:0007166)	439	9	9.67	-	.93	1.00E00
animal organ development (GO:0048513)	293	6	6.46	-	.93	1.00E00
nuclear export (GO:0051168)	49	1	1.08	-	.93	1.00E00
transcription by RNA polymerase II (GO:0006366)	49	1	1.08	-	.93	1.00E00
inorganic anion transport (GO:0015698)	49	1	1.08	-	.93	1.00E00
membrane fusion (GO:0061025)	49	1	1.08	-	.93	1.00E00
homeostatic process (GO:0042592)	196	4	4.32	-	.93	1.00E00
regulation of cellular catabolic process (GO:0031329)	98	2	2.16	-	.93	1.00E00
microtubule-based process (GO:0007017)	246	5	5.42	-	.92	1.00E00
cellular process (GO:0009987)	5614	114	123.71	-	.92	2.35E-01
system development (GO:0048731)	546	11	12.03	-	.91	8.82E-01
lipoprotein biosynthetic process (GO:0042158)	50	1	1.10	-	.91	1.00E00
protein lipidation (GO:0006497)	50	1	1.10	-	.91	1.00E00
protein dephosphorylation (GO:0006470)	50	1	1.10	-	.91	1.00E00
establishment or maintenance of cell polarity (GO:0007163)	50	1	1.10	-	.91	1.00E00
positive regulation of immune response (GO:0050778)	50	1	1.10	-	.91	1.00E00
cell development (GO:0048468)	300	6	6.61	-	.91	1.00E00
cellular response to stimulus (GO:0051716)	1418	28	31.25	-	.90	6.29E-01
cell communication (GO:0007154)	1270	25	27.98	-	.89	6.13E-01
heart development (GO:0007507)	51	1	1.12	-	.89	1.00E00
positive regulation of cell motility (GO:2000147)	51	1	1.12	-	.89	1.00E00
purine-containing compound biosynthetic process (GO:0072522)	51	1	1.12	-	.89	1.00E00
positive regulation of locomotion (GO:0040017)	51	1	1.12	-	.89	1.00E00
carbohydrate derivative biosynthetic process (GO:1901137)	205	4	4.52	-	.89	1.00E00
monoatomic ion transport (GO:0006811)	310	6	6.83	-	.88	1.00E00
signaling (GO:0023052)	1244	24	27.41	-	.88	5.41E-01
cellular metabolic process (GO:0044237)	2079	40	45.81	-	.87	3.66E-01
protein localization to membrane (GO:0072657)	104	2	2.29	-	.87	1.00E00
regulation of mRNA stability (GO:0043488)	52	1	1.15	-	.87	1.00E00
organic acid transmembrane transport (GO:1903825)	52	1	1.15	-	.87	1.00E00
carboxylic acid transmembrane transport (GO:1905039)	52	1	1.15	-	.87	1.00E00
developmental process (GO:0032502)	997	19	21.97	-	.86	5.74E-01
nucleotide metabolic process (GO:0009117)	105	2	2.31	-	.86	1.00E00
multicellular organismal process (GO:0032501)	840	16	18.51	-	.86	6.26E-01
transmembrane transport (GO:0055085)	421	8	9.28	-	.86	8.65E-01
regulation of biological quality (GO:0065008)	421	8	9.28	-	.86	8.65E-01
cellular nitrogen compound catabolic process (GO:0044270)	106	2	2.34	-	.86	1.00E00
regulation of RNA stability (GO:0043487)	53	1	1.17	-	.86	1.00E00
heterocycle catabolic process (GO:0046700)	106	2	2.34	-	.86	1.00E00
phosphatidylinositol biosynthetic process (GO:0006661)	53	1	1.17	-	.86	1.00E00
establishment of protein localization to membrane (GO:0090150)	53	1	1.17	-	.86	1.00E00
macromolecule metabolic process (GO:0043170)	1962	37	43.23	-	.86	3.14E-01
cellular component assembly (GO:0022607)	534	10	11.77	-	.85	7.62E-01
regulation of RNA metabolic process (GO:0051252)	1230	23	27.10	-	.85	4.72E-01
regulation of primary metabolic process (GO:0080090)	1553	29	34.22	-	.85	4.03E-01
macromolecule localization (GO:0033036)	538	10	11.86	-	.84	7.63E-01
metabolic process (GO:0008152)	2693	50	59.34	-	.84	1.79E-01
regulation of protein metabolic process (GO:0051246)	270	5	5.95	-	.84	1.00E00
cellular response to endogenous stimulus (GO:0071495)	163	3	3.59	-	.84	1.00E00
negative regulation of nitrogen compound metabolic process (GO:0051172)	272	5	5.99	-	.83	8.36E-01
protein transport (GO:0015031)	218	4	4.80	-	.83	1.00E00
cilium assembly (GO:0060271)	109	2	2.40	-	.83	1.00E00
monocarboxylic acid metabolic process (GO:0032787)	109	2	2.40	-	.83	1.00E00
negative regulation of macromolecule biosynthetic process (GO:0010558)	273	5	6.02	-	.83	8.36E-01
protein ubiquitination (GO:0016567)	164	3	3.61	-	.83	1.00E00
organic substance catabolic process (GO:1901575)	493	9	10.86	-	.83	7.53E-01
regulation of nitrogen compound metabolic process (GO:0051171)	1534	28	33.80	-	.83	3.06E-01
cell differentiation (GO:0030154)	603	11	13.29	-	.83	6.68E-01
cellular developmental process (GO:0048869)	603	11	13.29	-	.83	6.68E-01
canonical Wnt signaling pathway (GO:0060070)	55	1	1.21	-	.83	1.00E00
organelle fusion (GO:0048284)	55	1	1.21	-	.83	1.00E00
regulation of mRNA catabolic process (GO:0061013)	55	1	1.21	-	.83	1.00E00
apoptotic process (GO:0006915)	55	1	1.21	-	.83	1.00E00
negative regulation of biosynthetic process (GO:0009890)	275	5	6.06	-	.83	8.36E-01
negative regulation of cellular biosynthetic process (GO:0031327)	275	5	6.06	-	.83	8.36E-01
regulation of nucleobase-containing compound metabolic process (GO:0019219)	1269	23	27.96	-	.82	3.62E-01
intracellular protein transport (GO:0006886)	166	3	3.66	-	.82	1.00E00
regulation of macromolecule biosynthetic process (GO:0010556)	1440	26	31.73	-	.82	2.94E-01
establishment of localization in cell (GO:0051649)	499	9	11.00	-	.82	6.41E-01
localization (GO:0051179)	1443	26	31.80	-	.82	2.93E-01
immune system process (GO:0002376)	111	2	2.45	-	.82	1.00E00
ribonucleoprotein complex biogenesis (GO:0022613)	167	3	3.68	-	.82	1.00E00
regulation of cellular biosynthetic process (GO:0031326)	1448	26	31.91	-	.81	2.93E-01
regulation of cellular metabolic process (GO:0031323)	1671	30	36.82	-	.81	2.43E-01
primary metabolic process (GO:0044238)	2451	44	54.01	-	.81	1.42E-01
regulation of biosynthetic process (GO:0009889)	1453	26	32.02	-	.81	2.94E-01
lipoprotein metabolic process (GO:0042157)	56	1	1.23	-	.81	1.00E00
aromatic compound catabolic process (GO:0019439)	112	2	2.47	-	.81	1.00E00
regulation of cellular component size (GO:0032535)	56	1	1.23	-	.81	1.00E00
signal transduction (GO:0007165)	1121	20	24.70	-	.81	3.91E-01
nitrogen compound metabolic process (GO:0006807)	2243	40	49.43	-	.81	1.50E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	169	3	3.72	-	.81	1.00E00
chemical homeostasis (GO:0048878)	169	3	3.72	-	.81	1.00E00
nucleobase-containing compound biosynthetic process (GO:0034654)	169	3	3.72	-	.81	1.00E00
nucleoside phosphate metabolic process (GO:0006753)	113	2	2.49	-	.80	1.00E00
establishment of protein localization to organelle (GO:0072594)	113	2	2.49	-	.80	1.00E00
glycoprotein biosynthetic process (GO:0009101)	114	2	2.51	-	.80	1.00E00
membrane lipid biosynthetic process (GO:0046467)	57	1	1.26	-	.80	1.00E00
Wnt signaling pathway (GO:0016055)	57	1	1.26	-	.80	1.00E00
amino acid transport (GO:0006865)	57	1	1.26	-	.80	1.00E00
regulation of metabolic process (GO:0019222)	1772	31	39.05	-	.79	1.88E-01
regulation of macromolecule metabolic process (GO:0060255)	1664	29	36.67	-	.79	1.78E-01
regulation of cellular component organization (GO:0051128)	287	5	6.32	-	.79	8.37E-01
cellular catabolic process (GO:0044248)	287	5	6.32	-	.79	8.37E-01
negative regulation of gene expression (GO:0010629)	115	2	2.53	-	.79	1.00E00
gene expression (GO:0010467)	691	12	15.23	-	.79	5.03E-01
nucleotide biosynthetic process (GO:0009165)	58	1	1.28	-	.78	1.00E00
carbohydrate derivative catabolic process (GO:1901136)	58	1	1.28	-	.78	1.00E00
regulation of cellular component biogenesis (GO:0044087)	116	2	2.56	-	.78	1.00E00
negative regulation of cellular metabolic process (GO:0031324)	348	6	7.67	-	.78	7.10E-01
organic cyclic compound catabolic process (GO:1901361)	117	2	2.58	-	.78	1.00E00
organic substance metabolic process (GO:0071704)	2575	44	56.74	-	.78	5.77E-02
macromolecule biosynthetic process (GO:0009059)	879	15	19.37	-	.77	3.40E-01
regulation of DNA-templated transcription (GO:0006355)	1114	19	24.55	-	.77	2.83E-01
regulation of RNA biosynthetic process (GO:2001141)	1114	19	24.55	-	.77	2.83E-01
cellular lipid metabolic process (GO:0044255)	294	5	6.48	-	.77	6.89E-01
glycerophospholipid metabolic process (GO:0006650)	118	2	2.60	-	.77	1.00E00
intracellular transport (GO:0046907)	413	7	9.10	-	.77	6.08E-01
nucleoside phosphate biosynthetic process (GO:1901293)	59	1	1.30	-	.77	1.00E00
plasma membrane bounded cell projection assembly (GO:0120031)	118	2	2.60	-	.77	1.00E00
response to endoplasmic reticulum stress (GO:0034976)	59	1	1.30	-	.77	1.00E00
cell-cell signaling by wnt (GO:0198738)	59	1	1.30	-	.77	1.00E00
regulation of gene expression (GO:0010468)	1420	24	31.29	-	.77	1.77E-01
response to endogenous stimulus (GO:0009719)	178	3	3.92	-	.76	1.00E00
Golgi vesicle transport (GO:0048193)	119	2	2.62	-	.76	1.00E00
programmed cell death (GO:0012501)	60	1	1.32	-	.76	1.00E00
cell death (GO:0008219)	60	1	1.32	-	.76	1.00E00
regulation of actin filament organization (GO:0110053)	60	1	1.32	-	.76	1.00E00
negative regulation of catalytic activity (GO:0043086)	60	1	1.32	-	.76	1.00E00
protein metabolic process (GO:0019538)	1267	21	27.92	-	.75	1.87E-01
cellular localization (GO:0051641)	725	12	15.98	-	.75	3.60E-01
negative regulation of macromolecule metabolic process (GO:0010605)	364	6	8.02	-	.75	5.87E-01
regulation of intracellular signal transduction (GO:1902531)	243	4	5.35	-	.75	8.23E-01
cellular macromolecule localization (GO:0070727)	426	7	9.39	-	.75	5.04E-01
protein localization (GO:0008104)	426	7	9.39	-	.75	5.04E-01
translation (GO:0006412)	122	2	2.69	-	.74	1.00E00
lipid modification (GO:0030258)	61	1	1.34	-	.74	1.00E00
carbohydrate derivative metabolic process (GO:1901135)	307	5	6.76	-	.74	6.91E-01
positive regulation of cell population proliferation (GO:0008284)	62	1	1.37	-	.73	1.00E00
peptide biosynthetic process (GO:0043043)	125	2	2.75	-	.73	1.00E00
heterocycle biosynthetic process (GO:0018130)	188	3	4.14	-	.72	8.02E-01
negative regulation of metabolic process (GO:0009892)	376	6	8.29	-	.72	5.90E-01
vacuole organization (GO:0007033)	63	1	1.39	-	.72	1.00E00
cellular component biogenesis (GO:0044085)	631	10	13.90	-	.72	3.30E-01
protein modification by small protein conjugation (GO:0032446)	190	3	4.19	-	.72	8.02E-01
vesicle-mediated transport (GO:0016192)	444	7	9.78	-	.72	5.07E-01
aromatic compound biosynthetic process (GO:0019438)	192	3	4.23	-	.71	8.02E-01
generation of precursor metabolites and energy (GO:0006091)	64	1	1.41	-	.71	1.00E00
cell projection assembly (GO:0030031)	128	2	2.82	-	.71	1.00E00
small molecule metabolic process (GO:0044281)	386	6	8.51	-	.71	4.81E-01
transport (GO:0006810)	1231	19	27.13	-	.70	1.01E-01
RNA metabolic process (GO:0016070)	459	7	10.11	-	.69	4.15E-01
establishment of protein localization (GO:0045184)	263	4	5.80	-	.69	6.68E-01
glycoprotein metabolic process (GO:0009100)	132	2	2.91	-	.69	1.00E00
import across plasma membrane (GO:0098739)	66	1	1.45	-	.69	1.00E00
organonitrogen compound metabolic process (GO:1901564)	1584	24	34.90	-	.69	4.32E-02
lipid metabolic process (GO:0006629)	333	5	7.34	-	.68	5.66E-01
regulation of anatomical structure size (GO:0090066)	67	1	1.48	-	.68	1.00E00
positive regulation of protein metabolic process (GO:0051247)	134	2	2.95	-	.68	1.00E00
glycerolipid metabolic process (GO:0046486)	135	2	2.97	-	.67	7.72E-01
organophosphate metabolic process (GO:0019637)	271	4	5.97	-	.67	5.32E-01
positive regulation of immune system process (GO:0002684)	68	1	1.50	-	.67	1.00E00
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	68	1	1.50	-	.67	1.00E00
positive regulation of MAPK cascade (GO:0043410)	68	1	1.50	-	.67	1.00E00
cellular response to nitrogen compound (GO:1901699)	68	1	1.50	-	.67	1.00E00
regulation of catabolic process (GO:0009894)	136	2	3.00	-	.67	7.72E-01
regulation of transcription by RNA polymerase II (GO:0006357)	953	14	21.00	-	.67	1.33E-01
establishment of localization (GO:0051234)	1296	19	28.56	-	.67	5.65E-02
enzyme-linked receptor protein signaling pathway (GO:0007167)	206	3	4.54	-	.66	6.33E-01
nitrogen compound transport (GO:0071705)	345	5	7.60	-	.66	4.54E-01
glycerophospholipid biosynthetic process (GO:0046474)	69	1	1.52	-	.66	1.00E00
regulation of response to stress (GO:0080134)	69	1	1.52	-	.66	1.00E00
positive regulation of catabolic process (GO:0009896)	69	1	1.52	-	.66	1.00E00
embryo development (GO:0009790)	70	1	1.54	-	.65	1.00E00
cellular homeostasis (GO:0019725)	140	2	3.08	-	.65	7.72E-01
positive regulation of multicellular organismal process (GO:0051240)	70	1	1.54	-	.65	1.00E00
organic cyclic compound biosynthetic process (GO:1901362)	211	3	4.65	-	.65	6.34E-01
cellular nitrogen compound biosynthetic process (GO:0044271)	353	5	7.78	-	.64	4.58E-01
regulation of supramolecular fiber organization (GO:1902903)	71	1	1.56	-	.64	1.00E00
cellular biosynthetic process (GO:0044249)	1144	16	25.21	-	.63	5.57E-02
anatomical structure morphogenesis (GO:0009653)	359	5	7.91	-	.63	3.62E-01
phospholipid metabolic process (GO:0006644)	145	2	3.20	-	.63	7.74E-01
neuron projection morphogenesis (GO:0048812)	145	2	3.20	-	.63	7.74E-01
membrane lipid metabolic process (GO:0006643)	73	1	1.61	-	.62	1.00E00
cell projection morphogenesis (GO:0048858)	146	2	3.22	-	.62	7.74E-01
plasma membrane bounded cell projection morphogenesis (GO:0120039)	146	2	3.22	-	.62	7.74E-01
organic substance biosynthetic process (GO:1901576)	1172	16	25.83	-	.62	3.62E-02
biosynthetic process (GO:0009058)	1175	16	25.89	-	.62	3.61E-02
localization within membrane (GO:0051668)	147	2	3.24	-	.62	7.74E-01
organophosphate biosynthetic process (GO:0090407)	147	2	3.24	-	.62	7.74E-01
cellular response to chemical stimulus (GO:0070887)	222	3	4.89	-	.61	6.39E-01
organonitrogen compound biosynthetic process (GO:1901566)	453	6	9.98	-	.60	2.51E-01
amide biosynthetic process (GO:0043604)	154	2	3.39	-	.59	7.78E-01
phosphate-containing compound metabolic process (GO:0006796)	540	7	11.90	-	.59	1.75E-01
phosphorus metabolic process (GO:0006793)	543	7	11.97	-	.59	1.76E-01
nuclear transport (GO:0051169)	78	1	1.72	-	.58	1.00E00
nucleocytoplasmic transport (GO:0006913)	78	1	1.72	-	.58	1.00E00
response to organic substance (GO:0010033)	235	3	5.18	-	.58	4.97E-01
response to growth factor (GO:0070848)	79	1	1.74	-	.57	1.00E00
phospholipid biosynthetic process (GO:0008654)	79	1	1.74	-	.57	1.00E00
glycerolipid biosynthetic process (GO:0045017)	79	1	1.74	-	.57	1.00E00
cellular response to growth factor stimulus (GO:0071363)	79	1	1.74	-	.57	1.00E00
cellular response to organic substance (GO:0071310)	159	2	3.50	-	.57	5.89E-01
mitotic cell cycle (GO:0000278)	161	2	3.55	-	.56	5.89E-01
regulation of actin cytoskeleton organization (GO:0032956)	81	1	1.78	-	.56	1.00E00
intracellular signal transduction (GO:0035556)	327	4	7.21	-	.56	3.34E-01
regulation of actin filament-based process (GO:0032970)	82	1	1.81	-	.55	1.00E00
cellular component disassembly (GO:0022411)	82	1	1.81	-	.55	1.00E00
protein modification process (GO:0036211)	745	9	16.42	-	.55	5.32E-02
negative regulation of molecular function (GO:0044092)	83	1	1.83	-	.55	1.00E00
protein modification by small protein conjugation or removal (GO:0070647)	254	3	5.60	-	.54	3.83E-01
tRNA metabolic process (GO:0006399)	85	1	1.87	-	.53	1.00E00
cellular anatomical entity morphogenesis (GO:0032989)	171	2	3.77	-	.53	5.94E-01
negative regulation of RNA metabolic process (GO:0051253)	171	2	3.77	-	.53	5.94E-01
cellular response to oxygen-containing compound (GO:1901701)	86	1	1.90	-	.53	1.00E00
post-translational protein modification (GO:0043687)	268	3	5.91	-	.51	2.92E-01
protein localization to organelle (GO:0033365)	179	2	3.94	-	.51	4.44E-01
regulation of cell migration (GO:0030334)	91	1	2.01	-	.50	7.25E-01
positive regulation of cellular metabolic process (GO:0031325)	455	5	10.03	-	.50	1.39E-01
organic substance transport (GO:0071702)	461	5	10.16	-	.49	1.05E-01
macromolecule modification (GO:0043412)	830	9	18.29	-	.49	1.93E-02
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	185	2	4.08	-	.49	4.46E-01
regulation of apoptotic process (GO:0042981)	93	1	2.05	-	.49	7.25E-01
regulation of cell motility (GO:2000145)	94	1	2.07	-	.48	7.26E-01
regulation of locomotion (GO:0040012)	94	1	2.07	-	.48	7.26E-01
regulation of membrane potential (GO:0042391)	95	1	2.09	-	.48	7.26E-01
secretion by cell (GO:0032940)	96	1	2.12	-	.47	7.26E-01
cell motility (GO:0048870)	193	2	4.25	-	.47	4.51E-01
regulation of programmed cell death (GO:0043067)	97	1	2.14	-	.47	7.27E-01
regulation of cell population proliferation (GO:0042127)	98	1	2.16	-	.46	7.27E-01
carboxylic acid metabolic process (GO:0019752)	196	2	4.32	-	.46	4.54E-01
carboxylic acid transport (GO:0046942)	98	1	2.16	-	.46	7.27E-01
organic acid transport (GO:0015849)	98	1	2.16	-	.46	7.27E-01
organic acid metabolic process (GO:0006082)	198	2	4.36	-	.46	3.32E-01
oxoacid metabolic process (GO:0043436)	198	2	4.36	-	.46	3.32E-01
secretion (GO:0046903)	99	1	2.18	-	.46	7.28E-01
protein phosphorylation (GO:0006468)	199	2	4.39	-	.46	3.32E-01
RNA processing (GO:0006396)	300	3	6.61	-	.45	2.26E-01
amino acid metabolic process (GO:0006520)	100	1	2.20	-	.45	7.28E-01
positive regulation of metabolic process (GO:0009893)	504	5	11.11	-	.45	6.12E-02
axon guidance (GO:0007411)	101	1	2.23	-	.45	7.29E-01
neuron projection guidance (GO:0097485)	101	1	2.23	-	.45	7.29E-01
response to chemical (GO:0042221)	310	3	6.83	-	.44	1.68E-01
positive regulation of nitrogen compound metabolic process (GO:0051173)	416	4	9.17	-	.44	8.74E-02
post-transcriptional regulation of gene expression (GO:0010608)	104	1	2.29	-	.44	7.31E-01
mitochondrion organization (GO:0007005)	104	1	2.29	-	.44	7.31E-01
phosphorylation (GO:0016310)	212	2	4.67	-	.43	3.38E-01
response to oxygen-containing compound (GO:1901700)	109	1	2.40	-	.42	7.36E-01
export from cell (GO:0140352)	109	1	2.40	-	.42	7.36E-01
response to nitrogen compound (GO:1901698)	109	1	2.40	-	.42	7.36E-01
positive regulation of macromolecule metabolic process (GO:0010604)	437	4	9.63	-	.42	6.59E-02
system process (GO:0003008)	111	1	2.45	-	.41	5.23E-01
regulation of MAPK cascade (GO:0043408)	114	1	2.51	-	.40	5.23E-01
regulation of cytoskeleton organization (GO:0051493)	115	1	2.53	-	.39	5.24E-01
organelle localization (GO:0051640)	116	1	2.56	-	.39	5.24E-01
axonogenesis (GO:0007409)	120	1	2.64	-	.38	5.26E-01
organic anion transport (GO:0015711)	129	1	2.84	-	.35	5.36E-01
positive regulation of RNA metabolic process (GO:0051254)	261	2	5.75	-	.35	1.33E-01
axon development (GO:0061564)	137	1	3.02	-	.33	3.76E-01
cytoskeleton organization (GO:0007010)	412	3	9.08	-	.33	3.80E-02
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	282	2	6.21	-	.32	9.74E-02
negative regulation of DNA-templated transcription (GO:0045892)	152	1	3.35	-	.30	2.67E-01
negative regulation of RNA biosynthetic process (GO:1902679)	152	1	3.35	-	.30	2.67E-01
microtubule cytoskeleton organization (GO:0000226)	164	1	3.61	-	.28	2.74E-01
cell migration (GO:0016477)	169	1	3.72	-	.27	1.90E-01
lipid biosynthetic process (GO:0008610)	170	1	3.75	-	.27	1.90E-01
regulation of localization (GO:0032879)	204	1	4.50	-	.22	1.40E-01
ncRNA metabolic process (GO:0034660)	211	1	4.65	-	.22	9.50E-02
actin cytoskeleton organization (GO:0030036)	212	1	4.67	-	.21	9.52E-02
actin filament-based process (GO:0030029)	219	1	4.83	-	.21	9.73E-02
positive regulation of DNA-templated transcription (GO:0045893)	227	1	5.00	-	.20	6.66E-02
positive regulation of RNA biosynthetic process (GO:1902680)	227	1	5.00	-	.20	6.66E-02
positive regulation of macromolecule biosynthetic process (GO:0010557)	296	1	6.52	-	.15	2.40E-02
positive regulation of cellular biosynthetic process (GO:0031328)	301	1	6.63	-	.15	1.58E-02
positive regulation of biosynthetic process (GO:0009891)	302	1	6.65	-	.15	1.59E-02
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	2	0	.04	-	 < 0.01	1.00E00
ribonucleoside triphosphate metabolic process (GO:0009199)	23	0	.51	-	 < 0.01	1.00E00
mononuclear cell migration (GO:0071674)	4	0	.09	-	 < 0.01	1.00E00
intermediate filament organization (GO:0045109)	10	0	.22	-	 < 0.01	1.00E00
tissue morphogenesis (GO:0048729)	23	0	.51	-	 < 0.01	1.00E00
negative regulation of supramolecular fiber organization (GO:1902904)	32	0	.71	-	 < 0.01	1.00E00
centriole assembly (GO:0098534)	9	0	.20	-	 < 0.01	1.00E00
intermediate filament cytoskeleton organization (GO:0045104)	15	0	.33	-	 < 0.01	1.00E00
intermediate filament-based process (GO:0045103)	15	0	.33	-	 < 0.01	1.00E00
vitamin transport (GO:0051180)	12	0	.26	-	 < 0.01	1.00E00
TOR signaling (GO:0031929)	9	0	.20	-	 < 0.01	1.00E00
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	5	0	.11	-	 < 0.01	1.00E00
protein localization to mitochondrion (GO:0070585)	19	0	.42	-	 < 0.01	1.00E00
mitotic cytokinesis (GO:0000281)	14	0	.31	-	 < 0.01	1.00E00
negative regulation of actin filament polymerization (GO:0030837)	22	0	.48	-	 < 0.01	1.00E00
sperm-egg recognition (GO:0035036)	1	0	.02	-	 < 0.01	1.00E00
negative regulation of actin filament depolymerization (GO:0030835)	18	0	.40	-	 < 0.01	1.00E00
regulation of actin filament depolymerization (GO:0030834)	20	0	.44	-	 < 0.01	1.00E00
regulation of actin filament polymerization (GO:0030833)	42	0	.93	-	 < 0.01	1.00E00
regulation of actin filament length (GO:0030832)	45	0	.99	-	 < 0.01	6.27E-01
meiotic sister chromatid cohesion (GO:0051177)	2	0	.04	-	 < 0.01	1.00E00
cyclic nucleotide metabolic process (GO:0009187)	8	0	.18	-	 < 0.01	1.00E00
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	17	0	.37	-	 < 0.01	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	15	0	.33	-	 < 0.01	1.00E00
import into nucleus (GO:0051170)	36	0	.79	-	 < 0.01	1.00E00
supramolecular fiber organization (GO:0097435)	204	0	4.50	-	 < 0.01	2.52E-02
positive regulation of proteasomal protein catabolic process (GO:1901800)	17	0	.37	-	 < 0.01	1.00E00
polysaccharide biosynthetic process (GO:0000271)	9	0	.20	-	 < 0.01	1.00E00
lymphocyte mediated immunity (GO:0002449)	2	0	.04	-	 < 0.01	1.00E00
leukocyte mediated immunity (GO:0002443)	2	0	.04	-	 < 0.01	1.00E00
apoptotic cell clearance (GO:0043277)	4	0	.09	-	 < 0.01	1.00E00
oligodendrocyte differentiation (GO:0048709)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of monoatomic ion transport (GO:0043271)	17	0	.37	-	 < 0.01	1.00E00
regulation of lipid biosynthetic process (GO:0046890)	7	0	.15	-	 < 0.01	1.00E00
vesicle-mediated transport to the plasma membrane (GO:0098876)	52	0	1.15	-	 < 0.01	6.32E-01
endothelial cell differentiation (GO:0045446)	4	0	.09	-	 < 0.01	1.00E00
neutrophil migration (GO:1990266)	3	0	.07	-	 < 0.01	1.00E00
fat cell differentiation (GO:0045444)	2	0	.04	-	 < 0.01	1.00E00
axo-dendritic transport (GO:0008088)	16	0	.35	-	 < 0.01	1.00E00
regulation of establishment of protein localization (GO:0070201)	15	0	.33	-	 < 0.01	1.00E00
mitochondrial fission (GO:0000266)	8	0	.18	-	 < 0.01	1.00E00
regulation of monoatomic ion transport (GO:0043269)	68	0	1.50	-	 < 0.01	4.08E-01
positive regulation of hormone secretion (GO:0046887)	2	0	.04	-	 < 0.01	1.00E00
regulation of potassium ion transport (GO:0043266)	16	0	.35	-	 < 0.01	1.00E00
membrane invagination (GO:0010324)	11	0	.24	-	 < 0.01	1.00E00
regulation of peptide secretion (GO:0002791)	5	0	.11	-	 < 0.01	1.00E00
peptide secretion (GO:0002790)	3	0	.07	-	 < 0.01	1.00E00
regulation of hormone secretion (GO:0046883)	7	0	.15	-	 < 0.01	1.00E00
glucose 6-phosphate metabolic process (GO:0051156)	10	0	.22	-	 < 0.01	1.00E00
regulation of cell projection assembly (GO:0060491)	23	0	.51	-	 < 0.01	1.00E00
nucleoside catabolic process (GO:0009164)	8	0	.18	-	 < 0.01	1.00E00
negative regulation of protein catabolic process (GO:0042177)	11	0	.24	-	 < 0.01	1.00E00
regulation of protein catabolic process (GO:0042176)	43	0	.95	-	 < 0.01	1.00E00
response to interleukin-1 (GO:0070555)	2	0	.04	-	 < 0.01	1.00E00
immune response-activating cell surface receptor signaling pathway (GO:0002429)	30	0	.66	-	 < 0.01	1.00E00
cytokine-mediated signaling pathway (GO:0019221)	41	0	.90	-	 < 0.01	1.00E00
actin filament bundle organization (GO:0061572)	22	0	.48	-	 < 0.01	1.00E00
hormone secretion (GO:0046879)	3	0	.07	-	 < 0.01	1.00E00
mesenchyme development (GO:0060485)	31	0	.68	-	 < 0.01	1.00E00
ceramide biosynthetic process (GO:0046513)	24	0	.53	-	 < 0.01	1.00E00
regulation of protein-containing complex assembly (GO:0043254)	54	0	1.19	-	 < 0.01	6.34E-01
striated muscle cell differentiation (GO:0051146)	33	0	.73	-	 < 0.01	1.00E00
heme metabolic process (GO:0042168)	8	0	.18	-	 < 0.01	1.00E00
positive regulation of cell cycle (GO:0045787)	26	0	.57	-	 < 0.01	1.00E00
response to fatty acid (GO:0070542)	1	0	.02	-	 < 0.01	1.00E00
regulation of actin polymerization or depolymerization (GO:0008064)	43	0	.95	-	 < 0.01	1.00E00
regulation of lipid metabolic process (GO:0019216)	12	0	.26	-	 < 0.01	1.00E00
protein hydroxylation (GO:0018126)	14	0	.31	-	 < 0.01	1.00E00
glycerolipid catabolic process (GO:0046503)	14	0	.31	-	 < 0.01	1.00E00
regulation of protein-containing complex disassembly (GO:0043244)	36	0	.79	-	 < 0.01	1.00E00
negative regulation of protein-containing complex disassembly (GO:0043242)	26	0	.57	-	 < 0.01	1.00E00
multivesicular body sorting pathway (GO:0071985)	24	0	.53	-	 < 0.01	1.00E00
purine nucleoside triphosphate biosynthetic process (GO:0009145)	1	0	.02	-	 < 0.01	1.00E00
purine nucleoside triphosphate metabolic process (GO:0009144)	20	0	.44	-	 < 0.01	1.00E00
nucleoside triphosphate catabolic process (GO:0009143)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of cytoskeleton organization (GO:0051494)	33	0	.73	-	 < 0.01	1.00E00
nucleoside triphosphate biosynthetic process (GO:0009142)	6	0	.13	-	 < 0.01	1.00E00
chaperone-mediated protein complex assembly (GO:0051131)	4	0	.09	-	 < 0.01	1.00E00
nucleoside triphosphate metabolic process (GO:0009141)	30	0	.66	-	 < 0.01	1.00E00
regulation of stress fiber assembly (GO:0051492)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of blood pressure (GO:0045776)	6	0	.13	-	 < 0.01	1.00E00
protein K63-linked deubiquitination (GO:0070536)	7	0	.15	-	 < 0.01	1.00E00
protein K63-linked ubiquitination (GO:0070534)	5	0	.11	-	 < 0.01	1.00E00
mitochondrial fusion (GO:0008053)	9	0	.20	-	 < 0.01	1.00E00
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	31	0	.68	-	 < 0.01	1.00E00
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	6	0	.13	-	 < 0.01	1.00E00
immune response-regulating signaling pathway (GO:0002764)	37	0	.82	-	 < 0.01	1.00E00
phosphatidylinositol phosphate biosynthetic process (GO:0046854)	35	0	.77	-	 < 0.01	1.00E00
regulation of filopodium assembly (GO:0051489)	6	0	.13	-	 < 0.01	1.00E00
intracellular glucose homeostasis (GO:0001678)	6	0	.13	-	 < 0.01	1.00E00
regulation of bone remodeling (GO:0046850)	3	0	.07	-	 < 0.01	1.00E00
nucleoside diphosphate catabolic process (GO:0009134)	22	0	.48	-	 < 0.01	1.00E00
RNA polymerase II preinitiation complex assembly (GO:0051123)	6	0	.13	-	 < 0.01	1.00E00
long-chain fatty acid metabolic process (GO:0001676)	10	0	.22	-	 < 0.01	1.00E00
nucleoside diphosphate metabolic process (GO:0009132)	25	0	.55	-	 < 0.01	1.00E00
retrograde transport, endosome to Golgi (GO:0042147)	31	0	.68	-	 < 0.01	1.00E00
platelet aggregation (GO:0070527)	5	0	.11	-	 < 0.01	1.00E00
regulation of cytosolic calcium ion concentration (GO:0051480)	17	0	.37	-	 < 0.01	1.00E00
vacuole fusion, non-autophagic (GO:0042144)	1	0	.02	-	 < 0.01	1.00E00
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	1	0	.02	-	 < 0.01	1.00E00
regulation of sodium ion transmembrane transporter activity (GO:2000649)	13	0	.29	-	 < 0.01	1.00E00
motor neuron axon guidance (GO:0008045)	6	0	.13	-	 < 0.01	1.00E00
positive regulation of proteolysis involved in protein catabolic process (GO:1903052)	17	0	.37	-	 < 0.01	1.00E00
negative regulation of proteolysis involved in protein catabolic process (GO:1903051)	5	0	.11	-	 < 0.01	1.00E00
regulation of proteolysis involved in protein catabolic process (GO:1903050)	31	0	.68	-	 < 0.01	1.00E00
innate immune response-activating signaling pathway (GO:0002758)	12	0	.26	-	 < 0.01	1.00E00
immune response-activating signaling pathway (GO:0002757)	36	0	.79	-	 < 0.01	1.00E00
peptidyl-tyrosine phosphorylation (GO:0018108)	6	0	.13	-	 < 0.01	1.00E00
peptidyl-threonine phosphorylation (GO:0018107)	17	0	.37	-	 < 0.01	1.00E00
peptidyl-serine phosphorylation (GO:0018105)	74	0	1.63	-	 < 0.01	4.14E-01
filopodium assembly (GO:0046847)	3	0	.07	-	 < 0.01	1.00E00
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	4	0	.09	-	 < 0.01	1.00E00
skin development (GO:0043588)	3	0	.07	-	 < 0.01	1.00E00
ear development (GO:0043583)	2	0	.04	-	 < 0.01	1.00E00
regulation of amide metabolic process (GO:0034248)	49	0	1.08	-	 < 0.01	6.29E-01
ameboidal-type cell migration (GO:0001667)	36	0	.79	-	 < 0.01	1.00E00
response to hypoxia (GO:0001666)	16	0	.35	-	 < 0.01	1.00E00
meiotic DNA double-strand break formation (GO:0042138)	3	0	.07	-	 < 0.01	1.00E00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	8	0	.18	-	 < 0.01	1.00E00
regulation of transcription elongation by RNA polymerase II (GO:0034243)	9	0	.20	-	 < 0.01	1.00E00
cell recognition (GO:0008037)	14	0	.31	-	 < 0.01	1.00E00
mitotic cell cycle process (GO:1903047)	128	0	2.82	-	 < 0.01	1.21E-01
negative regulation of T cell proliferation (GO:0042130)	2	0	.04	-	 < 0.01	1.00E00
tRNA processing (GO:0008033)	52	0	1.15	-	 < 0.01	6.32E-01
V(D)J recombination (GO:0033151)	2	0	.04	-	 < 0.01	1.00E00
hippo signaling (GO:0035329)	15	0	.33	-	 < 0.01	1.00E00
carbohydrate phosphorylation (GO:0046835)	6	0	.13	-	 < 0.01	1.00E00
nucleoside metabolic process (GO:0009116)	14	0	.31	-	 < 0.01	1.00E00
cellular response to oxidative stress (GO:0034599)	9	0	.20	-	 < 0.01	1.00E00
regulation of T cell proliferation (GO:0042129)	3	0	.07	-	 < 0.01	1.00E00
eye development (GO:0001654)	31	0	.68	-	 < 0.01	1.00E00
calcium ion import (GO:0070509)	11	0	.24	-	 < 0.01	1.00E00
cytochrome complex assembly (GO:0017004)	2	0	.04	-	 < 0.01	1.00E00
nuclear chromosome segregation (GO:0098813)	54	0	1.19	-	 < 0.01	6.34E-01
negative regulation of Notch signaling pathway (GO:0045746)	3	0	.07	-	 < 0.01	1.00E00
regulation of microtubule cytoskeleton organization (GO:0070507)	32	0	.71	-	 < 0.01	1.00E00
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	3	0	.07	-	 < 0.01	1.00E00
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	4	0	.09	-	 < 0.01	1.00E00
regulation of leukocyte cell-cell adhesion (GO:1903037)	6	0	.13	-	 < 0.01	1.00E00
regulation of response to wounding (GO:1903034)	6	0	.13	-	 < 0.01	1.00E00
sperm motility (GO:0097722)	1	0	.02	-	 < 0.01	1.00E00
regulation of endopeptidase activity (GO:0052548)	41	0	.90	-	 < 0.01	1.00E00
calcineurin-mediated signaling (GO:0097720)	7	0	.15	-	 < 0.01	1.00E00
regulation of peptidase activity (GO:0052547)	42	0	.93	-	 < 0.01	1.00E00
positive regulation of gene expression (GO:0010628)	70	0	1.54	-	 < 0.01	4.09E-01
oligopeptide transmembrane transport (GO:0035672)	2	0	.04	-	 < 0.01	1.00E00
osteoblast differentiation (GO:0001649)	5	0	.11	-	 < 0.01	1.00E00
neutrophil activation (GO:0042119)	1	0	.02	-	 < 0.01	1.00E00
positive regulation of DNA repair (GO:0045739)	9	0	.20	-	 < 0.01	1.00E00
piRNA processing (GO:0034587)	6	0	.13	-	 < 0.01	1.00E00
negative regulation of DNA repair (GO:0045738)	5	0	.11	-	 < 0.01	1.00E00
regulation of intracellular pH (GO:0051453)	26	0	.57	-	 < 0.01	1.00E00
intracellular pH reduction (GO:0051452)	9	0	.20	-	 < 0.01	1.00E00
macrophage activation (GO:0042116)	1	0	.02	-	 < 0.01	1.00E00
odontogenesis (GO:0042476)	2	0	.04	-	 < 0.01	1.00E00
B cell activation (GO:0042113)	7	0	.15	-	 < 0.01	1.00E00
odontogenesis of dentin-containing tooth (GO:0042475)	2	0	.04	-	 < 0.01	1.00E00
positive regulation of protein catabolic process (GO:0045732)	24	0	.53	-	 < 0.01	1.00E00
regulation of heart contraction (GO:0008016)	20	0	.44	-	 < 0.01	1.00E00
blood circulation (GO:0008015)	39	0	.86	-	 < 0.01	1.00E00
T cell activation (GO:0042110)	7	0	.15	-	 < 0.01	1.00E00
inner ear morphogenesis (GO:0042472)	2	0	.04	-	 < 0.01	1.00E00
chromosome localization (GO:0050000)	13	0	.29	-	 < 0.01	1.00E00
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.02	-	 < 0.01	1.00E00
protein localization to cilium (GO:0061512)	15	0	.33	-	 < 0.01	1.00E00
centriole elongation (GO:0061511)	1	0	.02	-	 < 0.01	1.00E00
antigen processing and presentation (GO:0019882)	3	0	.07	-	 < 0.01	1.00E00
sperm axoneme assembly (GO:0007288)	1	0	.02	-	 < 0.01	1.00E00
cardiolipin biosynthetic process (GO:0032049)	2	0	.04	-	 < 0.01	1.00E00
epithelium development (GO:0060429)	35	0	.77	-	 < 0.01	1.00E00
spermatid development (GO:0007286)	4	0	.09	-	 < 0.01	1.00E00
regulation of dephosphorylation (GO:0035303)	9	0	.20	-	 < 0.01	1.00E00
spermatogenesis (GO:0007283)	17	0	.37	-	 < 0.01	1.00E00
germ cell development (GO:0007281)	16	0	.35	-	 < 0.01	1.00E00
mitochondrial DNA metabolic process (GO:0032042)	4	0	.09	-	 < 0.01	1.00E00
regulation of neuron projection development (GO:0010975)	40	0	.88	-	 < 0.01	1.00E00
carbohydrate transmembrane transport (GO:0034219)	9	0	.20	-	 < 0.01	1.00E00
positive regulation of translation (GO:0045727)	18	0	.40	-	 < 0.01	1.00E00
signal release (GO:0023061)	38	0	.84	-	 < 0.01	1.00E00
RNA modification (GO:0009451)	75	0	1.65	-	 < 0.01	4.16E-01
positive regulation of T cell proliferation (GO:0042102)	2	0	.04	-	 < 0.01	1.00E00
eye photoreceptor cell development (GO:0042462)	1	0	.02	-	 < 0.01	1.00E00
regulation of natural killer cell mediated immunity (GO:0002715)	2	0	.04	-	 < 0.01	1.00E00
gamete generation (GO:0007276)	27	0	.59	-	 < 0.01	1.00E00
neuromuscular synaptic transmission (GO:0007274)	10	0	.22	-	 < 0.01	1.00E00
regulation of mitotic sister chromatid separation (GO:0010965)	15	0	.33	-	 < 0.01	1.00E00
DNA geometric change (GO:0032392)	12	0	.26	-	 < 0.01	1.00E00
protein acylation (GO:0043543)	28	0	.62	-	 < 0.01	1.00E00
endothelial cell migration (GO:0043542)	4	0	.09	-	 < 0.01	1.00E00
lipid translocation (GO:0034204)	22	0	.48	-	 < 0.01	1.00E00
cGMP biosynthetic process (GO:0006182)	4	0	.09	-	 < 0.01	1.00E00
response to organic cyclic compound (GO:0014070)	27	0	.59	-	 < 0.01	1.00E00
neurotransmitter secretion (GO:0007269)	33	0	.73	-	 < 0.01	1.00E00
negative regulation of macroautophagy (GO:0016242)	4	0	.09	-	 < 0.01	1.00E00
regulation of macroautophagy (GO:0016241)	15	0	.33	-	 < 0.01	1.00E00
Rho protein signal transduction (GO:0007266)	25	0	.55	-	 < 0.01	1.00E00
Ras protein signal transduction (GO:0007265)	27	0	.59	-	 < 0.01	1.00E00
regulation of response to endoplasmic reticulum stress (GO:1905897)	6	0	.13	-	 < 0.01	1.00E00
small GTPase-mediated signal transduction (GO:0007264)	65	0	1.43	-	 < 0.01	4.06E-01
regulation of metal ion transport (GO:0010959)	52	0	1.15	-	 < 0.01	6.32E-01
positive regulation of insulin secretion (GO:0032024)	1	0	.02	-	 < 0.01	1.00E00
regulation of peptide transport (GO:0090087)	5	0	.11	-	 < 0.01	1.00E00
tyrosine phosphorylation of STAT protein (GO:0007260)	1	0	.02	-	 < 0.01	1.00E00
positive regulation of peptidase activity (GO:0010952)	20	0	.44	-	 < 0.01	1.00E00
negative regulation of endopeptidase activity (GO:0010951)	22	0	.48	-	 < 0.01	1.00E00
positive regulation of endopeptidase activity (GO:0010950)	19	0	.42	-	 < 0.01	1.00E00
replication fork processing (GO:0031297)	14	0	.31	-	 < 0.01	1.00E00
regulation of ERBB signaling pathway (GO:1901184)	12	0	.26	-	 < 0.01	1.00E00
hormone biosynthetic process (GO:0042446)	1	0	.02	-	 < 0.01	1.00E00
positive regulation of cell division (GO:0051781)	2	0	.04	-	 < 0.01	1.00E00
mitochondrial respiratory chain complex III assembly (GO:0034551)	1	0	.02	-	 < 0.01	1.00E00
mitochondrial respiratory chain complex assembly (GO:0033108)	10	0	.22	-	 < 0.01	1.00E00
positive regulation of macroautophagy (GO:0016239)	10	0	.22	-	 < 0.01	1.00E00
pigment metabolic process (GO:0042440)	13	0	.29	-	 < 0.01	1.00E00
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	1	0	.02	-	 < 0.01	1.00E00
telomere capping (GO:0016233)	3	0	.07	-	 < 0.01	1.00E00
receptor signaling pathway via JAK-STAT (GO:0007259)	8	0	.18	-	 < 0.01	1.00E00
JNK cascade (GO:0007254)	6	0	.13	-	 < 0.01	1.00E00
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	3	0	.07	-	 < 0.01	1.00E00
snRNA transcription by RNA polymerase II (GO:0042795)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of cyclase activity (GO:0031280)	2	0	.04	-	 < 0.01	1.00E00
collagen fibril organization (GO:0030199)	9	0	.20	-	 < 0.01	1.00E00
endosome to lysosome transport (GO:0008333)	14	0	.31	-	 < 0.01	1.00E00
iron-sulfur cluster assembly (GO:0016226)	9	0	.20	-	 < 0.01	1.00E00
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of blood coagulation (GO:0030195)	4	0	.09	-	 < 0.01	1.00E00
canonical NF-kappaB signal transduction (GO:0007249)	3	0	.07	-	 < 0.01	1.00E00
positive regulation of TOR signaling (GO:0032008)	15	0	.33	-	 < 0.01	1.00E00
negative regulation of TOR signaling (GO:0032007)	10	0	.22	-	 < 0.01	1.00E00
non-motile cilium assembly (GO:1905515)	14	0	.31	-	 < 0.01	1.00E00
regulation of TOR signaling (GO:0032006)	28	0	.62	-	 < 0.01	1.00E00
intracellular sterol transport (GO:0032366)	3	0	.07	-	 < 0.01	1.00E00
intracellular lipid transport (GO:0032365)	5	0	.11	-	 < 0.01	1.00E00
positive regulation of cell cycle process (GO:0090068)	25	0	.55	-	 < 0.01	1.00E00
response to light stimulus (GO:0009416)	24	0	.53	-	 < 0.01	1.00E00
neuron apoptotic process (GO:0051402)	4	0	.09	-	 < 0.01	1.00E00
response to UV (GO:0009411)	7	0	.15	-	 < 0.01	1.00E00
purine nucleoside catabolic process (GO:0006152)	3	0	.07	-	 < 0.01	1.00E00
regulation of cell-matrix adhesion (GO:0001952)	4	0	.09	-	 < 0.01	1.00E00
positive regulation of epithelial cell proliferation (GO:0050679)	7	0	.15	-	 < 0.01	1.00E00
protein deubiquitination (GO:0016579)	55	0	1.21	-	 < 0.01	6.35E-01
tRNA 3'-end processing (GO:0042780)	1	0	.02	-	 < 0.01	1.00E00
epithelial cell proliferation (GO:0050673)	1	0	.02	-	 < 0.01	1.00E00
regulation of lymphocyte proliferation (GO:0050670)	5	0	.11	-	 < 0.01	1.00E00
B cell differentiation (GO:0030183)	4	0	.09	-	 < 0.01	1.00E00
cellular component assembly involved in morphogenesis (GO:0010927)	25	0	.55	-	 < 0.01	1.00E00
developmental pigmentation (GO:0048066)	6	0	.13	-	 < 0.01	1.00E00
response to cold (GO:0009409)	1	0	.02	-	 < 0.01	1.00E00
response to heat (GO:0009408)	11	0	.24	-	 < 0.01	1.00E00
regulation of phosphatase activity (GO:0010921)	6	0	.13	-	 < 0.01	1.00E00
neural crest cell differentiation (GO:0014033)	29	0	.64	-	 < 0.01	1.00E00
neural crest cell development (GO:0014032)	29	0	.64	-	 < 0.01	1.00E00
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	6	0	.13	-	 < 0.01	1.00E00
ATP synthesis coupled electron transport (GO:0042773)	6	0	.13	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	3	0	.07	-	 < 0.01	1.00E00
signal transduction in response to DNA damage (GO:0042770)	20	0	.44	-	 < 0.01	1.00E00
smoothened signaling pathway (GO:0007224)	18	0	.40	-	 < 0.01	1.00E00
digestion (GO:0007586)	2	0	.04	-	 < 0.01	1.00E00
cellular response to topologically incorrect protein (GO:0035967)	26	0	.57	-	 < 0.01	1.00E00
response to topologically incorrect protein (GO:0035966)	26	0	.57	-	 < 0.01	1.00E00
endothelial cell proliferation (GO:0001935)	1	0	.02	-	 < 0.01	1.00E00
RNA transport (GO:0050658)	37	0	.82	-	 < 0.01	1.00E00
nucleic acid transport (GO:0050657)	37	0	.82	-	 < 0.01	1.00E00
platelet activation (GO:0030168)	6	0	.13	-	 < 0.01	1.00E00
protein import into peroxisome matrix (GO:0016558)	11	0	.24	-	 < 0.01	1.00E00
proteoglycan biosynthetic process (GO:0030166)	24	0	.53	-	 < 0.01	1.00E00
isoprenoid catabolic process (GO:0008300)	4	0	.09	-	 < 0.01	1.00E00
mRNA modification (GO:0016556)	8	0	.18	-	 < 0.01	1.00E00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	11	0	.24	-	 < 0.01	1.00E00
neuropeptide signaling pathway (GO:0007218)	31	0	.68	-	 < 0.01	1.00E00
regulation of proteolysis (GO:0030162)	76	0	1.67	-	 < 0.01	4.18E-01
glutamate receptor signaling pathway (GO:0007215)	10	0	.22	-	 < 0.01	1.00E00
dopamine receptor signaling pathway (GO:0007212)	6	0	.13	-	 < 0.01	1.00E00
response to glucose (GO:0009749)	4	0	.09	-	 < 0.01	1.00E00
protein N-linked glycosylation (GO:0006487)	35	0	.77	-	 < 0.01	1.00E00
protein localization to nucleus (GO:0034504)	42	0	.93	-	 < 0.01	1.00E00
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	1	0	.02	-	 < 0.01	1.00E00
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	3	0	.07	-	 < 0.01	1.00E00
protein localization to kinetochore (GO:0034501)	5	0	.11	-	 < 0.01	1.00E00
regulation of circadian rhythm (GO:0042752)	8	0	.18	-	 < 0.01	1.00E00
amino acid biosynthetic process (GO:0008652)	22	0	.48	-	 < 0.01	1.00E00
protein import into mitochondrial matrix (GO:0030150)	9	0	.20	-	 < 0.01	1.00E00
alanine transport (GO:0032328)	3	0	.07	-	 < 0.01	1.00E00
positive regulation of cytosolic calcium ion concentration (GO:0007204)	18	0	.40	-	 < 0.01	1.00E00
oxidative phosphorylation (GO:0006119)	6	0	.13	-	 < 0.01	1.00E00
energy reserve metabolic process (GO:0006112)	6	0	.13	-	 < 0.01	1.00E00
protein acetylation (GO:0006473)	6	0	.13	-	 < 0.01	1.00E00
regulation of leukocyte mediated cytotoxicity (GO:0001910)	2	0	.04	-	 < 0.01	1.00E00
sphingolipid catabolic process (GO:0030149)	11	0	.24	-	 < 0.01	1.00E00
defense response to bacterium (GO:0042742)	5	0	.11	-	 < 0.01	1.00E00
sphingolipid biosynthetic process (GO:0030148)	39	0	.86	-	 < 0.01	1.00E00
carbohydrate transport (GO:0008643)	9	0	.20	-	 < 0.01	1.00E00
signal peptide processing (GO:0006465)	4	0	.09	-	 < 0.01	1.00E00
sister chromatid segregation (GO:0000819)	41	0	.90	-	 < 0.01	1.00E00
apoptotic mitochondrial changes (GO:0008637)	10	0	.22	-	 < 0.01	1.00E00
proteinogenic amino acid metabolic process (GO:0170039)	38	0	.84	-	 < 0.01	1.00E00
proteinogenic amino acid biosynthetic process (GO:0170038)	20	0	.44	-	 < 0.01	1.00E00
negative regulation of angiogenesis (GO:0016525)	8	0	.18	-	 < 0.01	1.00E00
detection of mechanical stimulus (GO:0050982)	8	0	.18	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	12	0	.26	-	 < 0.01	1.00E00
L-amino acid biosynthetic process (GO:0170034)	20	0	.44	-	 < 0.01	1.00E00
L-amino acid metabolic process (GO:0170033)	47	0	1.04	-	 < 0.01	6.28E-01
negative regulation of chromosome separation (GO:1905819)	9	0	.20	-	 < 0.01	1.00E00
sex differentiation (GO:0007548)	4	0	.09	-	 < 0.01	1.00E00
regulation of chromosome separation (GO:1905818)	15	0	.33	-	 < 0.01	1.00E00
maturation of SSU-rRNA (GO:0030490)	27	0	.59	-	 < 0.01	1.00E00
'de novo' protein folding (GO:0006458)	8	0	.18	-	 < 0.01	1.00E00
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	9	0	.20	-	 < 0.01	1.00E00
biological process involved in interaction with host (GO:0051701)	1	0	.02	-	 < 0.01	1.00E00
RNA decapping (GO:0110154)	8	0	.18	-	 < 0.01	1.00E00
biomineral tissue development (GO:0031214)	4	0	.09	-	 < 0.01	1.00E00
mitotic intra-S DNA damage checkpoint signaling (GO:0031573)	4	0	.09	-	 < 0.01	1.00E00
DNA integrity checkpoint signaling (GO:0031570)	23	0	.51	-	 < 0.01	1.00E00
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	3	0	.07	-	 < 0.01	1.00E00
tRNA methylation (GO:0030488)	18	0	.40	-	 < 0.01	1.00E00
insulin-like growth factor receptor signaling pathway (GO:0048009)	5	0	.11	-	 < 0.01	1.00E00
regulation of translational initiation (GO:0006446)	10	0	.22	-	 < 0.01	1.00E00
nucleotide-sugar transmembrane transport (GO:0015780)	6	0	.13	-	 < 0.01	1.00E00
post-translational protein targeting to membrane, translocation (GO:0031204)	5	0	.11	-	 < 0.01	1.00E00
tRNA wobble uridine modification (GO:0002098)	7	0	.15	-	 < 0.01	1.00E00
neuromuscular junction development (GO:0007528)	9	0	.20	-	 < 0.01	1.00E00
negative regulation of intracellular signal transduction (GO:1902532)	57	0	1.26	-	 < 0.01	6.39E-01
attachment of spindle microtubules to kinetochore (GO:0008608)	7	0	.15	-	 < 0.01	1.00E00
sulfur compound metabolic process (GO:0006790)	71	0	1.56	-	 < 0.01	4.10E-01
lens development in camera-type eye (GO:0002088)	16	0	.35	-	 < 0.01	1.00E00
organelle transport along microtubule (GO:0072384)	25	0	.55	-	 < 0.01	1.00E00
sensory perception of mechanical stimulus (GO:0050954)	11	0	.24	-	 < 0.01	1.00E00
regulation of endocytosis (GO:0030100)	19	0	.42	-	 < 0.01	1.00E00
positive regulation of innate immune response (GO:0045089)	19	0	.42	-	 < 0.01	1.00E00
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	17	0	.37	-	 < 0.01	1.00E00
negative regulation of proteasomal protein catabolic process (GO:1901799)	5	0	.11	-	 < 0.01	1.00E00
heme biosynthetic process (GO:0006783)	5	0	.11	-	 < 0.01	1.00E00
protein activation cascade (GO:0072376)	5	0	.11	-	 < 0.01	1.00E00
alcohol biosynthetic process (GO:0046165)	31	0	.68	-	 < 0.01	1.00E00
protein-containing complex disassembly (GO:0032984)	41	0	.90	-	 < 0.01	1.00E00
regulation of translation (GO:0006417)	46	0	1.01	-	 < 0.01	6.27E-01
mitochondrial respiratory chain complex I assembly (GO:0032981)	6	0	.13	-	 < 0.01	1.00E00
mesoderm morphogenesis (GO:0048332)	7	0	.15	-	 < 0.01	1.00E00
porphyrin-containing compound metabolic process (GO:0006778)	10	0	.22	-	 < 0.01	1.00E00
translational termination (GO:0006415)	3	0	.07	-	 < 0.01	1.00E00
translational elongation (GO:0006414)	20	0	.44	-	 < 0.01	1.00E00
chromosome organization involved in meiotic cell cycle (GO:0070192)	11	0	.24	-	 < 0.01	1.00E00
organophosphate ester transport (GO:0015748)	46	0	1.01	-	 < 0.01	6.27E-01
citrate transport (GO:0015746)	4	0	.09	-	 < 0.01	1.00E00
succinate transport (GO:0015744)	3	0	.07	-	 < 0.01	1.00E00
mRNA export from nucleus (GO:0006406)	26	0	.57	-	 < 0.01	1.00E00
RNA export from nucleus (GO:0006405)	32	0	.71	-	 < 0.01	1.00E00
RNA localization (GO:0006403)	40	0	.88	-	 < 0.01	1.00E00
tRNA modification (GO:0006400)	38	0	.84	-	 < 0.01	1.00E00
folic acid-containing compound metabolic process (GO:0006760)	10	0	.22	-	 < 0.01	1.00E00
pigment biosynthetic process (GO:0046148)	10	0	.22	-	 < 0.01	1.00E00
positive regulation of chemotaxis (GO:0050921)	8	0	.18	-	 < 0.01	1.00E00
regulation of chemotaxis (GO:0050920)	8	0	.18	-	 < 0.01	1.00E00
positive regulation of transcription elongation by RNA polymerase II (GO:0032968)	7	0	.15	-	 < 0.01	1.00E00
mitotic spindle assembly (GO:0090307)	13	0	.29	-	 < 0.01	1.00E00
regulated exocytosis (GO:0045055)	30	0	.66	-	 < 0.01	1.00E00
axon extension (GO:0048675)	2	0	.04	-	 < 0.01	1.00E00
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	37	0	.82	-	 < 0.01	1.00E00
regulation of membrane lipid distribution (GO:0097035)	25	0	.55	-	 < 0.01	1.00E00
positive chemotaxis (GO:0050918)	2	0	.04	-	 < 0.01	1.00E00
regulation of transmembrane transporter activity (GO:0022898)	40	0	.88	-	 < 0.01	1.00E00
sensory perception of bitter taste (GO:0050913)	1	0	.02	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	1	0	.02	-	 < 0.01	1.00E00
chemical synaptic transmission, postsynaptic (GO:0099565)	4	0	.09	-	 < 0.01	1.00E00
siRNA processing (GO:0030422)	1	0	.02	-	 < 0.01	1.00E00
nicotinamide nucleotide metabolic process (GO:0046496)	30	0	.66	-	 < 0.01	1.00E00
sprouting angiogenesis (GO:0002040)	8	0	.18	-	 < 0.01	1.00E00
synaptic membrane adhesion (GO:0099560)	5	0	.11	-	 < 0.01	1.00E00
protein insertion into ER membrane (GO:0045048)	3	0	.07	-	 < 0.01	1.00E00
protein targeting to ER (GO:0045047)	12	0	.26	-	 < 0.01	1.00E00
glutathione metabolic process (GO:0006749)	14	0	.31	-	 < 0.01	1.00E00
bile acid and bile salt transport (GO:0015721)	5	0	.11	-	 < 0.01	1.00E00
ubiquinone biosynthetic process (GO:0006744)	5	0	.11	-	 < 0.01	1.00E00
sensory perception of taste (GO:0050909)	2	0	.04	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception (GO:0050907)	2	0	.04	-	 < 0.01	1.00E00
detection of stimulus involved in sensory perception (GO:0050906)	6	0	.13	-	 < 0.01	1.00E00
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	4	0	.09	-	 < 0.01	1.00E00
signal transduction by p53 class mediator (GO:0072331)	5	0	.11	-	 < 0.01	1.00E00
monocarboxylic acid biosynthetic process (GO:0072330)	27	0	.59	-	 < 0.01	1.00E00
leukocyte migration (GO:0050900)	9	0	.20	-	 < 0.01	1.00E00
monocarboxylic acid transport (GO:0015718)	34	0	.75	-	 < 0.01	1.00E00
protein insertion into mitochondrial inner membrane (GO:0045039)	3	0	.07	-	 < 0.01	1.00E00
regulation of mononuclear cell proliferation (GO:0032944)	5	0	.11	-	 < 0.01	1.00E00
mononuclear cell proliferation (GO:0032943)	1	0	.02	-	 < 0.01	1.00E00
NADP metabolic process (GO:0006739)	4	0	.09	-	 < 0.01	1.00E00
monocarboxylic acid catabolic process (GO:0072329)	33	0	.73	-	 < 0.01	1.00E00
regulation of sodium ion transport (GO:0002028)	20	0	.44	-	 < 0.01	1.00E00
glycerophospholipid catabolic process (GO:0046475)	8	0	.18	-	 < 0.01	1.00E00
phosphatidylcholine metabolic process (GO:0046470)	7	0	.15	-	 < 0.01	1.00E00
SREBP signaling pathway (GO:0032933)	6	0	.13	-	 < 0.01	1.00E00
anatomical structure formation involved in morphogenesis (GO:0048646)	83	0	1.83	-	 < 0.01	2.67E-01
early endosome to late endosome transport (GO:0045022)	4	0	.09	-	 < 0.01	1.00E00
lymphocyte migration (GO:0072676)	3	0	.07	-	 < 0.01	1.00E00
monosaccharide metabolic process (GO:0005996)	27	0	.59	-	 < 0.01	1.00E00
regulation of postsynaptic membrane potential (GO:0060078)	11	0	.24	-	 < 0.01	1.00E00
acylglycerol catabolic process (GO:0046464)	9	0	.20	-	 < 0.01	1.00E00
cellular response to lipopolysaccharide (GO:0071222)	9	0	.20	-	 < 0.01	1.00E00
neutral lipid catabolic process (GO:0046461)	9	0	.20	-	 < 0.01	1.00E00
activin receptor signaling pathway (GO:0032924)	3	0	.07	-	 < 0.01	1.00E00
circadian regulation of gene expression (GO:0032922)	20	0	.44	-	 < 0.01	1.00E00
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	11	0	.24	-	 < 0.01	1.00E00
positive regulation of DNA-binding transcription factor activity (GO:0051091)	17	0	.37	-	 < 0.01	1.00E00
regulation of DNA-binding transcription factor activity (GO:0051090)	25	0	.55	-	 < 0.01	1.00E00
morphogenesis of an epithelium (GO:0002009)	13	0	.29	-	 < 0.01	1.00E00
autophagosome maturation (GO:0097352)	7	0	.15	-	 < 0.01	1.00E00
small molecule biosynthetic process (GO:0044283)	106	0	2.34	-	 < 0.01	1.78E-01
small molecule catabolic process (GO:0044282)	83	0	1.83	-	 < 0.01	2.67E-01
leukocyte activation involved in immune response (GO:0002366)	3	0	.07	-	 < 0.01	1.00E00
TORC2 signaling (GO:0038203)	4	0	.09	-	 < 0.01	1.00E00
cellular response to molecule of bacterial origin (GO:0071219)	9	0	.20	-	 < 0.01	1.00E00
TORC1 signaling (GO:0038202)	1	0	.02	-	 < 0.01	1.00E00
icosanoid biosynthetic process (GO:0046456)	7	0	.15	-	 < 0.01	1.00E00
cellular response to biotic stimulus (GO:0071216)	9	0	.20	-	 < 0.01	1.00E00
positive regulation of cell cycle G1/S phase transition (GO:1902808)	8	0	.18	-	 < 0.01	1.00E00
leucine biosynthetic process (GO:0009098)	1	0	.02	-	 < 0.01	1.00E00
chaperone cofactor-dependent protein refolding (GO:0051085)	6	0	.13	-	 < 0.01	1.00E00
response to oxygen levels (GO:0070482)	17	0	.37	-	 < 0.01	1.00E00
protein localization to plasma membrane (GO:0072659)	45	0	.99	-	 < 0.01	6.27E-01
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	12	0	.26	-	 < 0.01	1.00E00
establishment of protein localization to mitochondrion (GO:0072655)	19	0	.42	-	 < 0.01	1.00E00
sulfur compound catabolic process (GO:0044273)	7	0	.15	-	 < 0.01	1.00E00
glycogen biosynthetic process (GO:0005978)	2	0	.04	-	 < 0.01	1.00E00
vesicle cytoskeletal trafficking (GO:0099518)	16	0	.35	-	 < 0.01	1.00E00
glycogen metabolic process (GO:0005977)	6	0	.13	-	 < 0.01	1.00E00
polysaccharide metabolic process (GO:0005976)	13	0	.29	-	 < 0.01	1.00E00
carbohydrate metabolic process (GO:0005975)	78	0	1.72	-	 < 0.01	4.21E-01
tube development (GO:0035295)	40	0	.88	-	 < 0.01	1.00E00
response to organonitrogen compound (GO:0010243)	86	0	1.90	-	 < 0.01	2.68E-01
lysine biosynthetic process (GO:0009085)	1	0	.02	-	 < 0.01	1.00E00
cellular response to transforming growth factor beta stimulus (GO:0071560)	20	0	.44	-	 < 0.01	1.00E00
branched-chain amino acid biosynthetic process (GO:0009082)	2	0	.04	-	 < 0.01	1.00E00
branched-chain amino acid metabolic process (GO:0009081)	9	0	.20	-	 < 0.01	1.00E00
rRNA base methylation (GO:0070475)	5	0	.11	-	 < 0.01	1.00E00
ncRNA transcription (GO:0098781)	14	0	.31	-	 < 0.01	1.00E00
regulation of proteasomal protein catabolic process (GO:0061136)	30	0	.66	-	 < 0.01	1.00E00
receptor signaling pathway via STAT (GO:0097696)	8	0	.18	-	 < 0.01	1.00E00
cardiac muscle contraction (GO:0060048)	15	0	.33	-	 < 0.01	1.00E00
heart contraction (GO:0060047)	19	0	.42	-	 < 0.01	1.00E00
response to transforming growth factor beta (GO:0071559)	20	0	.44	-	 < 0.01	1.00E00
vesicle fusion to plasma membrane (GO:0099500)	6	0	.13	-	 < 0.01	1.00E00
retina development in camera-type eye (GO:0060041)	1	0	.02	-	 < 0.01	1.00E00
multicellular organismal reproductive process (GO:0048609)	29	0	.64	-	 < 0.01	1.00E00
cellular response to amino acid starvation (GO:0034198)	9	0	.20	-	 < 0.01	1.00E00
reproductive structure development (GO:0048608)	2	0	.04	-	 < 0.01	1.00E00
aromatic amino acid family catabolic process (GO:0009074)	9	0	.20	-	 < 0.01	1.00E00
aromatic amino acid metabolic process (GO:0009072)	12	0	.26	-	 < 0.01	1.00E00
MAPK cascade (GO:0000165)	19	0	.42	-	 < 0.01	1.00E00
positive regulation of leukocyte activation (GO:0002696)	5	0	.11	-	 < 0.01	1.00E00
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	2	0	.04	-	 < 0.01	1.00E00
negative regulation of leukocyte activation (GO:0002695)	6	0	.13	-	 < 0.01	1.00E00
regulation of leukocyte activation (GO:0002694)	11	0	.24	-	 < 0.01	1.00E00
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	6	0	.13	-	 < 0.01	1.00E00
microtubule polymerization (GO:0046785)	19	0	.42	-	 < 0.01	1.00E00
negative regulation of small GTPase mediated signal transduction (GO:0051058)	10	0	.22	-	 < 0.01	1.00E00
positive regulation of leukocyte chemotaxis (GO:0002690)	8	0	.18	-	 < 0.01	1.00E00
aspartate family amino acid biosynthetic process (GO:0009067)	8	0	.18	-	 < 0.01	1.00E00
aspartate family amino acid metabolic process (GO:0009066)	12	0	.26	-	 < 0.01	1.00E00
negative regulation of DNA metabolic process (GO:0051053)	13	0	.29	-	 < 0.01	1.00E00
amino acid catabolic process (GO:0009063)	31	0	.68	-	 < 0.01	1.00E00
regulation of DNA metabolic process (GO:0051052)	34	0	.75	-	 < 0.01	1.00E00
fatty acid catabolic process (GO:0009062)	30	0	.66	-	 < 0.01	1.00E00
negative regulation of transport (GO:0051051)	30	0	.66	-	 < 0.01	1.00E00
positive regulation of transport (GO:0051050)	36	0	.79	-	 < 0.01	1.00E00
aerobic respiration (GO:0009060)	28	0	.62	-	 < 0.01	1.00E00
phospholipid translocation (GO:0045332)	21	0	.46	-	 < 0.01	1.00E00
rRNA modification (GO:0000154)	17	0	.37	-	 < 0.01	1.00E00
protein O-linked mannosylation (GO:0035269)	5	0	.11	-	 < 0.01	1.00E00
cellular lipid catabolic process (GO:0044242)	61	0	1.34	-	 < 0.01	6.46E-01
protein mannosylation (GO:0035268)	8	0	.18	-	 < 0.01	1.00E00
positive regulation of leukocyte migration (GO:0002687)	12	0	.26	-	 < 0.01	1.00E00
regulation of leukocyte migration (GO:0002685)	15	0	.33	-	 < 0.01	1.00E00
regulation of transport (GO:0051049)	160	0	3.53	-	 < 0.01	5.29E-02
DNA biosynthetic process (GO:0071897)	19	0	.42	-	 < 0.01	1.00E00
positive regulation of secretion (GO:0051047)	7	0	.15	-	 < 0.01	1.00E00
regulation of secretion (GO:0051046)	43	0	.95	-	 < 0.01	1.00E00
regulation of monoatomic cation transmembrane transport (GO:1904062)	45	0	.99	-	 < 0.01	6.27E-01
detoxification (GO:0098754)	6	0	.13	-	 < 0.01	1.00E00
late endosome to vacuole transport (GO:0045324)	27	0	.59	-	 < 0.01	1.00E00
gliogenesis (GO:0042063)	16	0	.35	-	 < 0.01	1.00E00
leukocyte activation (GO:0045321)	18	0	.40	-	 < 0.01	1.00E00
protein localization to lysosome (GO:0061462)	6	0	.13	-	 < 0.01	1.00E00
stress fiber assembly (GO:0043149)	5	0	.11	-	 < 0.01	1.00E00
regulation of double-strand break repair via homologous recombination (GO:0010569)	6	0	.13	-	 < 0.01	1.00E00
intracellular signaling cassette (GO:0141124)	152	0	3.35	-	 < 0.01	8.42E-02
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	11	0	.24	-	 < 0.01	1.00E00
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	1	0	.02	-	 < 0.01	1.00E00
reproductive system development (GO:0061458)	2	0	.04	-	 < 0.01	1.00E00
establishment of mitotic spindle orientation (GO:0000132)	9	0	.20	-	 < 0.01	1.00E00
synaptic transmission, glutamatergic (GO:0035249)	17	0	.37	-	 < 0.01	1.00E00
mRNA transport (GO:0051028)	28	0	.62	-	 < 0.01	1.00E00
phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0043491)	8	0	.18	-	 < 0.01	1.00E00
phospholipid catabolic process (GO:0009395)	12	0	.26	-	 < 0.01	1.00E00
fluid transport (GO:0042044)	7	0	.15	-	 < 0.01	1.00E00
regulation of neuron differentiation (GO:0045664)	9	0	.20	-	 < 0.01	1.00E00
vasculogenesis (GO:0001570)	4	0	.09	-	 < 0.01	1.00E00
exocytic process (GO:0140029)	13	0	.29	-	 < 0.01	1.00E00
negative regulation of transcription by RNA polymerase II (GO:0000122)	112	0	2.47	-	 < 0.01	1.83E-01
endosomal transport (GO:0016197)	98	0	2.16	-	 < 0.01	2.82E-01
tube morphogenesis (GO:0035239)	38	0	.84	-	 < 0.01	1.00E00
RNA stabilization (GO:0043489)	14	0	.31	-	 < 0.01	1.00E00
negative regulation of canonical NF-kappaB signal transduction (GO:0043124)	5	0	.11	-	 < 0.01	1.00E00
actin filament bundle assembly (GO:0051017)	21	0	.46	-	 < 0.01	1.00E00
barbed-end actin filament capping (GO:0051016)	17	0	.37	-	 < 0.01	1.00E00
toll-like receptor 4 signaling pathway (GO:0034142)	5	0	.11	-	 < 0.01	1.00E00
isoprenoid biosynthetic process (GO:0008299)	11	0	.24	-	 < 0.01	1.00E00
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	4	0	.09	-	 < 0.01	1.00E00
mitotic nuclear division (GO:0140014)	41	0	.90	-	 < 0.01	1.00E00
maturation of LSU-rRNA (GO:0000470)	17	0	.37	-	 < 0.01	1.00E00
snRNA processing (GO:0016180)	19	0	.42	-	 < 0.01	1.00E00
bone development (GO:0060348)	7	0	.15	-	 < 0.01	1.00E00
regulation of protein localization to membrane (GO:1905475)	10	0	.22	-	 < 0.01	1.00E00
regulation of cellular localization (GO:0060341)	47	0	1.04	-	 < 0.01	6.28E-01
pigmentation (GO:0043473)	13	0	.29	-	 < 0.01	1.00E00
negative regulation of mitotic sister chromatid segregation (GO:0033048)	9	0	.20	-	 < 0.01	1.00E00
regulation of mitotic sister chromatid segregation (GO:0033047)	10	0	.22	-	 < 0.01	1.00E00
insulin receptor signaling pathway (GO:0008286)	7	0	.15	-	 < 0.01	1.00E00
negative regulation of sister chromatid segregation (GO:0033046)	9	0	.20	-	 < 0.01	1.00E00
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	7	0	.15	-	 < 0.01	1.00E00
negative regulation of cell population proliferation (GO:0008285)	14	0	.31	-	 < 0.01	1.00E00
regulation of sister chromatid segregation (GO:0033045)	19	0	.42	-	 < 0.01	1.00E00
cell population proliferation (GO:0008283)	7	0	.15	-	 < 0.01	1.00E00
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	11	0	.24	-	 < 0.01	1.00E00
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	17	0	.37	-	 < 0.01	1.00E00
triglyceride catabolic process (GO:0019433)	3	0	.07	-	 < 0.01	1.00E00
triglyceride biosynthetic process (GO:0019432)	10	0	.22	-	 < 0.01	1.00E00
maturation of 5.8S rRNA (GO:0000460)	15	0	.33	-	 < 0.01	1.00E00
secondary metabolite biosynthetic process (GO:0044550)	4	0	.09	-	 < 0.01	1.00E00
type I interferon-mediated signaling pathway (GO:0060337)	2	0	.04	-	 < 0.01	1.00E00
negative regulation of adenylate cyclase activity (GO:0007194)	2	0	.04	-	 < 0.01	1.00E00
protein palmitoylation (GO:0018345)	20	0	.44	-	 < 0.01	1.00E00
positive regulation of myeloid cell differentiation (GO:0045639)	4	0	.09	-	 < 0.01	1.00E00
regulation of myeloid cell differentiation (GO:0045637)	6	0	.13	-	 < 0.01	1.00E00
negative regulation of lyase activity (GO:0051350)	2	0	.04	-	 < 0.01	1.00E00
cell chemotaxis (GO:0060326)	16	0	.35	-	 < 0.01	1.00E00
regulation of phospholipase activity (GO:0010517)	1	0	.02	-	 < 0.01	1.00E00
head development (GO:0060322)	44	0	.97	-	 < 0.01	1.00E00
tricarboxylic acid cycle (GO:0006099)	16	0	.35	-	 < 0.01	1.00E00
negative regulation of hydrolase activity (GO:0051346)	25	0	.55	-	 < 0.01	1.00E00
glycolytic process (GO:0006096)	16	0	.35	-	 < 0.01	1.00E00
retina homeostasis (GO:0001895)	2	0	.04	-	 < 0.01	1.00E00
tissue homeostasis (GO:0001894)	4	0	.09	-	 < 0.01	1.00E00
snRNA 3'-end processing (GO:0034472)	17	0	.37	-	 < 0.01	1.00E00
amino acid import across plasma membrane (GO:0089718)	9	0	.20	-	 < 0.01	1.00E00
ncRNA processing (GO:0034470)	170	0	3.75	-	 < 0.01	5.66E-02
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	2	0	.04	-	 < 0.01	1.00E00
transforming growth factor beta receptor signaling pathway (GO:0007179)	20	0	.44	-	 < 0.01	1.00E00
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	31	0	.68	-	 < 0.01	1.00E00
positive regulation of autophagy (GO:0010508)	16	0	.35	-	 < 0.01	1.00E00
negative regulation of autophagy (GO:0010507)	9	0	.20	-	 < 0.01	1.00E00
epidermal growth factor receptor signaling pathway (GO:0007173)	14	0	.31	-	 < 0.01	1.00E00
regulation of autophagy (GO:0010506)	35	0	.77	-	 < 0.01	1.00E00
homotypic cell-cell adhesion (GO:0034109)	7	0	.15	-	 < 0.01	1.00E00
liver development (GO:0001889)	2	0	.04	-	 < 0.01	1.00E00
angiogenesis (GO:0001525)	32	0	.71	-	 < 0.01	1.00E00
regulation of tissue remodeling (GO:0034103)	3	0	.07	-	 < 0.01	1.00E00
regulation of autophagosome maturation (GO:1901096)	5	0	.11	-	 < 0.01	1.00E00
pseudouridine synthesis (GO:0001522)	11	0	.24	-	 < 0.01	1.00E00
tetrapyrrole metabolic process (GO:0033013)	12	0	.26	-	 < 0.01	1.00E00
negative regulation of cell adhesion (GO:0007162)	10	0	.22	-	 < 0.01	1.00E00
response to peptide hormone (GO:0043434)	30	0	.66	-	 < 0.01	1.00E00
negative regulation of DNA-binding transcription factor activity (GO:0043433)	8	0	.18	-	 < 0.01	1.00E00
glycerol-3-phosphate metabolic process (GO:0006072)	5	0	.11	-	 < 0.01	1.00E00
RNA methylation (GO:0001510)	39	0	.86	-	 < 0.01	1.00E00
mitophagy (GO:0000423)	11	0	.24	-	 < 0.01	1.00E00
secretory granule organization (GO:0033363)	2	0	.04	-	 < 0.01	1.00E00
leukocyte cell-cell adhesion (GO:0007159)	1	0	.02	-	 < 0.01	1.00E00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	25	0	.55	-	 < 0.01	1.00E00
positive regulation of protein polymerization (GO:0032273)	13	0	.29	-	 < 0.01	1.00E00
protein transmembrane transport (GO:0071806)	27	0	.59	-	 < 0.01	1.00E00
negative regulation of protein polymerization (GO:0032272)	22	0	.48	-	 < 0.01	1.00E00
regulation of protein polymerization (GO:0032271)	48	0	1.06	-	 < 0.01	6.28E-01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	5	0	.11	-	 < 0.01	1.00E00
substrate adhesion-dependent cell spreading (GO:0034446)	13	0	.29	-	 < 0.01	1.00E00
ossification (GO:0001503)	13	0	.29	-	 < 0.01	1.00E00
metaphase chromosome alignment (GO:0051310)	9	0	.20	-	 < 0.01	1.00E00
skeletal system development (GO:0001501)	39	0	.86	-	 < 0.01	1.00E00
protein localization to cell periphery (GO:1990778)	52	0	1.15	-	 < 0.01	6.32E-01
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	3	0	.07	-	 < 0.01	1.00E00
lipid oxidation (GO:0034440)	23	0	.51	-	 < 0.01	1.00E00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	2	0	.04	-	 < 0.01	1.00E00
myeloid cell differentiation (GO:0030099)	10	0	.22	-	 < 0.01	1.00E00
taxis (GO:0042330)	35	0	.77	-	 < 0.01	1.00E00
muscle cell differentiation (GO:0042692)	40	0	.88	-	 < 0.01	1.00E00
phytosteroid metabolic process (GO:0016128)	1	0	.02	-	 < 0.01	1.00E00
secondary metabolic process (GO:0019748)	5	0	.11	-	 < 0.01	1.00E00
lymphocyte differentiation (GO:0030098)	10	0	.22	-	 < 0.01	1.00E00
hemopoiesis (GO:0030097)	27	0	.59	-	 < 0.01	1.00E00
protein peptidyl-prolyl isomerization (GO:0000413)	14	0	.31	-	 < 0.01	1.00E00
sterol biosynthetic process (GO:0016126)	12	0	.26	-	 < 0.01	1.00E00
regulation of Notch signaling pathway (GO:0008593)	12	0	.26	-	 < 0.01	1.00E00
sterol metabolic process (GO:0016125)	21	0	.46	-	 < 0.01	1.00E00
cytosolic transport (GO:0016482)	35	0	.77	-	 < 0.01	1.00E00
male meiotic nuclear division (GO:0007140)	4	0	.09	-	 < 0.01	1.00E00
macromolecule methylation (GO:0043414)	53	0	1.17	-	 < 0.01	6.33E-01
telomere maintenance via telomere lengthening (GO:0010833)	8	0	.18	-	 < 0.01	1.00E00
mitotic sister chromatid separation (GO:0051306)	1	0	.02	-	 < 0.01	1.00E00
chromosome separation (GO:0051304)	3	0	.07	-	 < 0.01	1.00E00
response to radiation (GO:0009314)	30	0	.66	-	 < 0.01	1.00E00
establishment of chromosome localization (GO:0051303)	13	0	.29	-	 < 0.01	1.00E00
regulation of cell division (GO:0051302)	7	0	.15	-	 < 0.01	1.00E00
oligosaccharide biosynthetic process (GO:0009312)	2	0	.04	-	 < 0.01	1.00E00
positive regulation of transcription by RNA polymerase II (GO:0045944)	190	0	4.19	-	 < 0.01	2.35E-02
positive regulation of transcription by RNA polymerase I (GO:0045943)	3	0	.07	-	 < 0.01	1.00E00
syncytium formation by plasma membrane fusion (GO:0000768)	3	0	.07	-	 < 0.01	1.00E00
carotenoid biosynthetic process (GO:0016117)	1	0	.02	-	 < 0.01	1.00E00
male gonad development (GO:0008584)	1	0	.02	-	 < 0.01	1.00E00
cholesterol efflux (GO:0033344)	8	0	.18	-	 < 0.01	1.00E00
terpenoid biosynthetic process (GO:0016114)	4	0	.09	-	 < 0.01	1.00E00
antimicrobial humoral response (GO:0019730)	1	0	.02	-	 < 0.01	1.00E00
methylation (GO:0032259)	53	0	1.17	-	 < 0.01	6.33E-01
mesoderm development (GO:0007498)	7	0	.15	-	 < 0.01	1.00E00
negative regulation of MAPK cascade (GO:0043409)	24	0	.53	-	 < 0.01	1.00E00
endoderm development (GO:0007492)	7	0	.15	-	 < 0.01	1.00E00
amine metabolic process (GO:0009308)	18	0	.40	-	 < 0.01	1.00E00
regulation of centrosome duplication (GO:0010824)	6	0	.13	-	 < 0.01	1.00E00
steroid hormone mediated signaling pathway (GO:0043401)	3	0	.07	-	 < 0.01	1.00E00
UDP-N-acetylglucosamine metabolic process (GO:0006047)	5	0	.11	-	 < 0.01	1.00E00
regulation of mitochondrion organization (GO:0010821)	10	0	.22	-	 < 0.01	1.00E00
establishment of organelle localization (GO:0051656)	85	0	1.87	-	 < 0.01	2.67E-01
rRNA transcription (GO:0009303)	6	0	.13	-	 < 0.01	1.00E00
rRNA methylation (GO:0031167)	10	0	.22	-	 < 0.01	1.00E00
phagolysosome assembly (GO:0001845)	9	0	.20	-	 < 0.01	1.00E00
spindle localization (GO:0051653)	17	0	.37	-	 < 0.01	1.00E00
maintenance of location in cell (GO:0051651)	18	0	.40	-	 < 0.01	1.00E00
establishment of vesicle localization (GO:0051650)	34	0	.75	-	 < 0.01	1.00E00
amino sugar metabolic process (GO:0006040)	14	0	.31	-	 < 0.01	1.00E00
regulation of blood pressure (GO:0008217)	13	0	.29	-	 < 0.01	1.00E00
positive regulation of mitotic cell cycle (GO:0045931)	15	0	.33	-	 < 0.01	1.00E00
negative regulation of mitotic sister chromatid separation (GO:2000816)	9	0	.20	-	 < 0.01	1.00E00
insulin secretion (GO:0030073)	2	0	.04	-	 < 0.01	1.00E00
homologous chromosome pairing at meiosis (GO:0007129)	6	0	.13	-	 < 0.01	1.00E00
calcium-mediated signaling (GO:0019722)	30	0	.66	-	 < 0.01	1.00E00
peptide hormone secretion (GO:0030072)	3	0	.07	-	 < 0.01	1.00E00
regulation of mitotic metaphase/anaphase transition (GO:0030071)	16	0	.35	-	 < 0.01	1.00E00
cell cycle G1/S phase transition (GO:0044843)	18	0	.40	-	 < 0.01	1.00E00
regulation of vesicle-mediated transport (GO:0060627)	59	0	1.30	-	 < 0.01	6.42E-01
vesicle localization (GO:0051648)	35	0	.77	-	 < 0.01	1.00E00
release of cytochrome c from mitochondria (GO:0001836)	5	0	.11	-	 < 0.01	1.00E00
positive regulation of growth (GO:0045927)	4	0	.09	-	 < 0.01	1.00E00
centrosome localization (GO:0051642)	8	0	.18	-	 < 0.01	1.00E00
mitochondrial transcription (GO:0006390)	6	0	.13	-	 < 0.01	1.00E00
cholesterol metabolic process (GO:0008203)	15	0	.33	-	 < 0.01	1.00E00
cell cycle G2/M phase transition (GO:0044839)	3	0	.07	-	 < 0.01	1.00E00
steroid metabolic process (GO:0008202)	27	0	.59	-	 < 0.01	1.00E00
proteoglycan metabolic process (GO:0006029)	29	0	.64	-	 < 0.01	1.00E00
left/right pattern formation (GO:0060972)	2	0	.04	-	 < 0.01	1.00E00
glucose transmembrane transport (GO:1904659)	7	0	.15	-	 < 0.01	1.00E00
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	4	0	.09	-	 < 0.01	1.00E00
glycosaminoglycan biosynthetic process (GO:0006024)	14	0	.31	-	 < 0.01	1.00E00
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	14	0	.31	-	 < 0.01	1.00E00
aminoglycan biosynthetic process (GO:0006023)	18	0	.40	-	 < 0.01	1.00E00
anaphase-promoting complex-dependent catabolic process (GO:0031145)	8	0	.18	-	 < 0.01	1.00E00
regulation of monoatomic ion transmembrane transport (GO:0034765)	59	0	1.30	-	 < 0.01	6.42E-01
aminoglycan metabolic process (GO:0006022)	25	0	.55	-	 < 0.01	1.00E00
kidney development (GO:0001822)	8	0	.18	-	 < 0.01	1.00E00
transcription by RNA polymerase III (GO:0006383)	14	0	.31	-	 < 0.01	1.00E00
adenosine to inosine editing (GO:0006382)	4	0	.09	-	 < 0.01	1.00E00
regulation of transmembrane transport (GO:0034762)	69	0	1.52	-	 < 0.01	4.09E-01
negative regulation of DNA recombination (GO:0045910)	5	0	.11	-	 < 0.01	1.00E00
mitotic DNA replication checkpoint signaling (GO:0033314)	3	0	.07	-	 < 0.01	1.00E00
DNA synthesis involved in DNA repair (GO:0000731)	13	0	.29	-	 < 0.01	1.00E00
somatic cell DNA recombination (GO:0016444)	2	0	.04	-	 < 0.01	1.00E00
regulation of organelle assembly (GO:1902115)	21	0	.46	-	 < 0.01	1.00E00
positive regulation of cytokine production (GO:0001819)	9	0	.20	-	 < 0.01	1.00E00
regulation of cytokine production (GO:0001817)	23	0	.51	-	 < 0.01	1.00E00
mRNA polyadenylation (GO:0006378)	5	0	.11	-	 < 0.01	1.00E00
response to toxic substance (GO:0009636)	8	0	.18	-	 < 0.01	1.00E00
cytokine production (GO:0001816)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of chromosome segregation (GO:0051985)	9	0	.20	-	 < 0.01	1.00E00
iron ion transmembrane transport (GO:0034755)	5	0	.11	-	 < 0.01	1.00E00
regulation of chromosome segregation (GO:0051983)	21	0	.46	-	 < 0.01	1.00E00
DNA double-strand break processing (GO:0000729)	4	0	.09	-	 < 0.01	1.00E00
double-strand break repair via break-induced replication (GO:0000727)	9	0	.20	-	 < 0.01	1.00E00
actin filament-based movement (GO:0030048)	16	0	.35	-	 < 0.01	1.00E00
epidermis development (GO:0008544)	4	0	.09	-	 < 0.01	1.00E00
mitotic G2/M transition checkpoint (GO:0044818)	12	0	.26	-	 < 0.01	1.00E00
telomere maintenance (GO:0000723)	26	0	.57	-	 < 0.01	1.00E00
actin filament depolymerization (GO:0030042)	8	0	.18	-	 < 0.01	1.00E00
actin filament polymerization (GO:0030041)	10	0	.22	-	 < 0.01	1.00E00
regulation of peptide hormone secretion (GO:0090276)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	9	0	.20	-	 < 0.01	1.00E00
response to abiotic stimulus (GO:0009628)	72	0	1.59	-	 < 0.01	4.12E-01
glucose metabolic process (GO:0006006)	17	0	.37	-	 < 0.01	1.00E00
transcription elongation by RNA polymerase II (GO:0006368)	9	0	.20	-	 < 0.01	1.00E00
cell-cell recognition (GO:0009988)	1	0	.02	-	 < 0.01	1.00E00
regulation of potassium ion transmembrane transport (GO:1901379)	14	0	.31	-	 < 0.01	1.00E00
rRNA processing (GO:0006364)	81	0	1.78	-	 < 0.01	4.28E-01
mRNA 3'-end processing (GO:0031124)	16	0	.35	-	 < 0.01	1.00E00
RNA 3'-end processing (GO:0031123)	40	0	.88	-	 < 0.01	1.00E00
transcription elongation by RNA polymerase I (GO:0006362)	2	0	.04	-	 < 0.01	1.00E00
cytoplasmic microtubule organization (GO:0031122)	21	0	.46	-	 < 0.01	1.00E00
transcription by RNA polymerase I (GO:0006360)	10	0	.22	-	 < 0.01	1.00E00
lipid homeostasis (GO:0055088)	25	0	.55	-	 < 0.01	1.00E00
cholesterol homeostasis (GO:0042632)	8	0	.18	-	 < 0.01	1.00E00
contractile actin filament bundle assembly (GO:0030038)	5	0	.11	-	 < 0.01	1.00E00
respiratory chain complex IV assembly (GO:0008535)	1	0	.02	-	 < 0.01	1.00E00
resolution of meiotic recombination intermediates (GO:0000712)	11	0	.24	-	 < 0.01	1.00E00
intracellular chemical homeostasis (GO:0055082)	117	0	2.58	-	 < 0.01	1.89E-01
regulation of postsynapse organization (GO:0099175)	9	0	.20	-	 < 0.01	1.00E00
postsynapse organization (GO:0099173)	6	0	.13	-	 < 0.01	1.00E00
regulation of telomere maintenance (GO:0032204)	6	0	.13	-	 < 0.01	1.00E00
quaternary ammonium group transport (GO:0015697)	5	0	.11	-	 < 0.01	1.00E00
telomere organization (GO:0032200)	26	0	.57	-	 < 0.01	1.00E00
organic cation transport (GO:0015695)	6	0	.13	-	 < 0.01	1.00E00
defense response to virus (GO:0051607)	4	0	.09	-	 < 0.01	1.00E00
response to bacterium (GO:0009617)	16	0	.35	-	 < 0.01	1.00E00
detection of stimulus (GO:0051606)	24	0	.53	-	 < 0.01	1.00E00
response to virus (GO:0009615)	4	0	.09	-	 < 0.01	1.00E00
regulation of synaptic transmission, glutamatergic (GO:0051966)	13	0	.29	-	 < 0.01	1.00E00
regulation of transcription by RNA polymerase I (GO:0006356)	4	0	.09	-	 < 0.01	1.00E00
positive regulation of synapse assembly (GO:0051965)	9	0	.20	-	 < 0.01	1.00E00
DNA-templated transcription elongation (GO:0006354)	11	0	.24	-	 < 0.01	1.00E00
response to mechanical stimulus (GO:0009612)	9	0	.20	-	 < 0.01	1.00E00
regulation of microtubule polymerization or depolymerization (GO:0031110)	20	0	.44	-	 < 0.01	1.00E00
sodium ion homeostasis (GO:0055078)	11	0	.24	-	 < 0.01	1.00E00
nervous system process (GO:0050877)	61	0	1.34	-	 < 0.01	6.46E-01
positive regulation of secretion by cell (GO:1903532)	7	0	.15	-	 < 0.01	1.00E00
positive regulation of T cell activation (GO:0050870)	3	0	.07	-	 < 0.01	1.00E00
regulation of secretion by cell (GO:1903530)	42	0	.93	-	 < 0.01	1.00E00
regulation of muscle system process (GO:0090257)	11	0	.24	-	 < 0.01	1.00E00
microtubule polymerization or depolymerization (GO:0031109)	29	0	.64	-	 < 0.01	1.00E00
DNA methylation-dependent heterochromatin formation (GO:0006346)	2	0	.04	-	 < 0.01	1.00E00
negative regulation of T cell activation (GO:0050868)	4	0	.09	-	 < 0.01	1.00E00
positive regulation of cell activation (GO:0050867)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of cell activation (GO:0050866)	6	0	.13	-	 < 0.01	1.00E00
regulation of cell activation (GO:0050865)	13	0	.29	-	 < 0.01	1.00E00
regulation of T cell activation (GO:0050863)	6	0	.13	-	 < 0.01	1.00E00
response to lipid (GO:0033993)	34	0	.75	-	 < 0.01	1.00E00
adenosine metabolic process (GO:0046085)	4	0	.09	-	 < 0.01	1.00E00
establishment of cell polarity (GO:0030010)	22	0	.48	-	 < 0.01	1.00E00
regulation of receptor-mediated endocytosis (GO:0048259)	6	0	.13	-	 < 0.01	1.00E00
sensory organ development (GO:0007423)	46	0	1.01	-	 < 0.01	6.27E-01
peripheral nervous system development (GO:0007422)	2	0	.04	-	 < 0.01	1.00E00
brain development (GO:0007420)	44	0	.97	-	 < 0.01	1.00E00
mRNA stabilization (GO:0048255)	13	0	.29	-	 < 0.01	1.00E00
cholesterol biosynthetic process (GO:0006695)	7	0	.15	-	 < 0.01	1.00E00
dorsal/ventral pattern formation (GO:0009953)	7	0	.15	-	 < 0.01	1.00E00
steroid biosynthetic process (GO:0006694)	15	0	.33	-	 < 0.01	1.00E00
anterior/posterior pattern specification (GO:0009952)	38	0	.84	-	 < 0.01	1.00E00
regulation of systemic arterial blood pressure (GO:0003073)	9	0	.20	-	 < 0.01	1.00E00
prostaglandin metabolic process (GO:0006693)	5	0	.11	-	 < 0.01	1.00E00
icosanoid metabolic process (GO:0006690)	10	0	.22	-	 < 0.01	1.00E00
regulation of cell adhesion mediated by integrin (GO:0033628)	5	0	.11	-	 < 0.01	1.00E00
B cell receptor signaling pathway (GO:0050853)	9	0	.20	-	 < 0.01	1.00E00
T cell receptor signaling pathway (GO:0050852)	17	0	.37	-	 < 0.01	1.00E00
intracellular monoatomic cation homeostasis (GO:0030003)	106	0	2.34	-	 < 0.01	1.78E-01
antigen receptor-mediated signaling pathway (GO:0050851)	22	0	.48	-	 < 0.01	1.00E00
lytic vacuole organization (GO:0080171)	14	0	.31	-	 < 0.01	1.00E00
central nervous system development (GO:0007417)	76	0	1.67	-	 < 0.01	4.18E-01
synapse assembly (GO:0007416)	23	0	.51	-	 < 0.01	1.00E00
macrophage chemotaxis (GO:0048246)	1	0	.02	-	 < 0.01	1.00E00
sensory organ morphogenesis (GO:0090596)	8	0	.18	-	 < 0.01	1.00E00
glycosphingolipid biosynthetic process (GO:0006688)	11	0	.24	-	 < 0.01	1.00E00
sperm capacitation (GO:0048240)	1	0	.02	-	 < 0.01	1.00E00
positive regulation of establishment of protein localization (GO:1904951)	6	0	.13	-	 < 0.01	1.00E00
mitochondrial cytochrome c oxidase assembly (GO:0033617)	1	0	.02	-	 < 0.01	1.00E00
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	3	0	.07	-	 < 0.01	1.00E00
regulation of microtubule-based process (GO:0032886)	47	0	1.04	-	 < 0.01	6.28E-01
embryonic morphogenesis (GO:0048598)	40	0	.88	-	 < 0.01	1.00E00
mitotic cytokinetic process (GO:1902410)	2	0	.04	-	 < 0.01	1.00E00
male gamete generation (GO:0048232)	18	0	.40	-	 < 0.01	1.00E00
regulation of protein localization (GO:0032880)	37	0	.82	-	 < 0.01	1.00E00
camera-type eye morphogenesis (GO:0048593)	4	0	.09	-	 < 0.01	1.00E00
eye morphogenesis (GO:0048592)	6	0	.13	-	 < 0.01	1.00E00
regulation of calcium ion transport (GO:0051924)	20	0	.44	-	 < 0.01	1.00E00
mitotic recombination (GO:0006312)	6	0	.13	-	 < 0.01	1.00E00
ceramide metabolic process (GO:0006672)	37	0	.82	-	 < 0.01	1.00E00
P-body assembly (GO:0033962)	9	0	.20	-	 < 0.01	1.00E00
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	19	0	.42	-	 < 0.01	1.00E00
DNA catabolic process (GO:0006308)	4	0	.09	-	 < 0.01	1.00E00
DNA methylation (GO:0006306)	5	0	.11	-	 < 0.01	1.00E00
DNA alkylation (GO:0006305)	5	0	.11	-	 < 0.01	1.00E00
DNA modification (GO:0006304)	12	0	.26	-	 < 0.01	1.00E00
sphingolipid metabolic process (GO:0006665)	53	0	1.17	-	 < 0.01	6.33E-01
double-strand break repair via nonhomologous end joining (GO:0006303)	16	0	.35	-	 < 0.01	1.00E00
postreplication repair (GO:0006301)	14	0	.31	-	 < 0.01	1.00E00
dipeptide transport (GO:0042938)	2	0	.04	-	 < 0.01	1.00E00
vesicle transport along microtubule (GO:0047496)	16	0	.35	-	 < 0.01	1.00E00
defense response to Gram-negative bacterium (GO:0050829)	1	0	.02	-	 < 0.01	1.00E00
negative regulation of cell migration (GO:0030336)	10	0	.22	-	 < 0.01	1.00E00
protein stabilization (GO:0050821)	12	0	.26	-	 < 0.01	1.00E00
endosome transport via multivesicular body sorting pathway (GO:0032509)	24	0	.53	-	 < 0.01	1.00E00
DNA duplex unwinding (GO:0032508)	12	0	.26	-	 < 0.01	1.00E00
cellular response to insulin stimulus (GO:0032869)	16	0	.35	-	 < 0.01	1.00E00
cytokinetic process (GO:0032506)	10	0	.22	-	 < 0.01	1.00E00
response to insulin (GO:0032868)	18	0	.40	-	 < 0.01	1.00E00
multicellular organism reproduction (GO:0032504)	29	0	.64	-	 < 0.01	1.00E00
hormone transport (GO:0009914)	3	0	.07	-	 < 0.01	1.00E00
phosphatidylcholine biosynthetic process (GO:0006656)	2	0	.04	-	 < 0.01	1.00E00
epidermal cell differentiation (GO:0009913)	2	0	.04	-	 < 0.01	1.00E00
negative regulation of coagulation (GO:0050819)	5	0	.11	-	 < 0.01	1.00E00
regulation of coagulation (GO:0050818)	7	0	.15	-	 < 0.01	1.00E00
regulation of cellular response to stress (GO:0080135)	30	0	.66	-	 < 0.01	1.00E00
ATP metabolic process (GO:0046034)	18	0	.40	-	 < 0.01	1.00E00
carboxylic acid catabolic process (GO:0046395)	68	0	1.50	-	 < 0.01	4.08E-01
carboxylic acid biosynthetic process (GO:0046394)	55	0	1.21	-	 < 0.01	6.35E-01
embryonic organ development (GO:0048568)	28	0	.62	-	 < 0.01	1.00E00
glycosyl compound catabolic process (GO:1901658)	13	0	.29	-	 < 0.01	1.00E00
glycosyl compound metabolic process (GO:1901657)	23	0	.51	-	 < 0.01	1.00E00
triglyceride metabolic process (GO:0006641)	16	0	.35	-	 < 0.01	1.00E00
cellular response to peptide (GO:1901653)	25	0	.55	-	 < 0.01	1.00E00
establishment of protein localization to endoplasmic reticulum (GO:0072599)	12	0	.26	-	 < 0.01	1.00E00
response to peptide (GO:1901652)	30	0	.66	-	 < 0.01	1.00E00
synapse organization (GO:0050808)	64	0	1.41	-	 < 0.01	4.06E-01
cardiac muscle cell differentiation (GO:0055007)	7	0	.15	-	 < 0.01	1.00E00
regulation of synapse organization (GO:0050807)	18	0	.40	-	 < 0.01	1.00E00
positive regulation of protein localization (GO:1903829)	12	0	.26	-	 < 0.01	1.00E00
melanocyte differentiation (GO:0030318)	1	0	.02	-	 < 0.01	1.00E00
flagellated sperm motility (GO:0030317)	1	0	.02	-	 < 0.01	1.00E00
striated muscle cell development (GO:0055002)	25	0	.55	-	 < 0.01	1.00E00
regulation of synapse structure or activity (GO:0050803)	19	0	.42	-	 < 0.01	1.00E00
osteoclast differentiation (GO:0030316)	4	0	.09	-	 < 0.01	1.00E00
muscle cell development (GO:0055001)	34	0	.75	-	 < 0.01	1.00E00
acylglycerol metabolic process (GO:0006639)	22	0	.48	-	 < 0.01	1.00E00
neutral lipid metabolic process (GO:0006638)	22	0	.48	-	 < 0.01	1.00E00
acyl-CoA metabolic process (GO:0006637)	17	0	.37	-	 < 0.01	1.00E00
unsaturated fatty acid biosynthetic process (GO:0006636)	6	0	.13	-	 < 0.01	1.00E00
fatty acid beta-oxidation (GO:0006635)	21	0	.46	-	 < 0.01	1.00E00
heart process (GO:0003015)	20	0	.44	-	 < 0.01	1.00E00
fatty acid biosynthetic process (GO:0006633)	27	0	.59	-	 < 0.01	1.00E00
circulatory system process (GO:0003013)	42	0	.93	-	 < 0.01	1.00E00
chaperone-mediated protein folding (GO:0061077)	12	0	.26	-	 < 0.01	1.00E00
ERBB signaling pathway (GO:0038127)	15	0	.33	-	 < 0.01	1.00E00
cellular process involved in reproduction in multicellular organism (GO:0022412)	23	0	.51	-	 < 0.01	1.00E00
clathrin-dependent endocytosis (GO:0072583)	11	0	.24	-	 < 0.01	1.00E00
T cell activation involved in immune response (GO:0002286)	2	0	.04	-	 < 0.01	1.00E00
lymphocyte activation involved in immune response (GO:0002285)	2	0	.04	-	 < 0.01	1.00E00
DNA demethylation (GO:0080111)	6	0	.13	-	 < 0.01	1.00E00
cholesterol transport (GO:0030301)	11	0	.24	-	 < 0.01	1.00E00
macrophage activation involved in immune response (GO:0002281)	1	0	.02	-	 < 0.01	1.00E00
positive regulation of cation channel activity (GO:2001259)	5	0	.11	-	 < 0.01	1.00E00
response to steroid hormone (GO:0048545)	8	0	.18	-	 < 0.01	1.00E00
skeletal muscle contraction (GO:0003009)	8	0	.18	-	 < 0.01	1.00E00
negative regulation of chromosome organization (GO:2001251)	10	0	.22	-	 < 0.01	1.00E00
transforming growth factor beta receptor superfamily signaling pathway (GO:0141091)	31	0	.68	-	 < 0.01	1.00E00
heart morphogenesis (GO:0003007)	12	0	.26	-	 < 0.01	1.00E00
protein processing involved in protein targeting to mitochondrion (GO:0006627)	1	0	.02	-	 < 0.01	1.00E00
protein targeting to mitochondrion (GO:0006626)	18	0	.40	-	 < 0.01	1.00E00
developmental process involved in reproduction (GO:0003006)	26	0	.57	-	 < 0.01	1.00E00
response to unfolded protein (GO:0006986)	19	0	.42	-	 < 0.01	1.00E00
regionalization (GO:0003002)	47	0	1.04	-	 < 0.01	6.28E-01
protein targeting to lysosome (GO:0006622)	2	0	.04	-	 < 0.01	1.00E00
positive regulation of cell-cell adhesion (GO:0022409)	9	0	.20	-	 < 0.01	1.00E00
post-translational protein targeting to endoplasmic reticulum membrane (GO:0006620)	7	0	.15	-	 < 0.01	1.00E00
negative regulation of cell-cell adhesion (GO:0022408)	7	0	.15	-	 < 0.01	1.00E00
regulation of cell-cell adhesion (GO:0022407)	15	0	.33	-	 < 0.01	1.00E00
myeloid leukocyte activation (GO:0002274)	2	0	.04	-	 < 0.01	1.00E00
visual system development (GO:0150063)	31	0	.68	-	 < 0.01	1.00E00
cellular response to light stimulus (GO:0071482)	8	0	.18	-	 < 0.01	1.00E00
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	4	0	.09	-	 < 0.01	1.00E00
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	7	0	.15	-	 < 0.01	1.00E00
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	7	0	.15	-	 < 0.01	1.00E00
interstrand cross-link repair (GO:0036297)	11	0	.24	-	 < 0.01	1.00E00
cotranslational protein targeting to membrane (GO:0006613)	7	0	.15	-	 < 0.01	1.00E00
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	2	0	.04	-	 < 0.01	1.00E00
response to osmotic stress (GO:0006970)	4	0	.09	-	 < 0.01	1.00E00
cell activation involved in immune response (GO:0002263)	3	0	.07	-	 < 0.01	1.00E00
regulation of cellular pH (GO:0030641)	27	0	.59	-	 < 0.01	1.00E00
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	4	0	.09	-	 < 0.01	1.00E00
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	11	0	.24	-	 < 0.01	1.00E00
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	15	0	.33	-	 < 0.01	1.00E00
positive regulation of apoptotic signaling pathway (GO:2001235)	8	0	.18	-	 < 0.01	1.00E00
negative regulation of apoptotic signaling pathway (GO:2001234)	16	0	.35	-	 < 0.01	1.00E00
regulation of apoptotic signaling pathway (GO:2001233)	24	0	.53	-	 < 0.01	1.00E00
NLS-bearing protein import into nucleus (GO:0006607)	10	0	.22	-	 < 0.01	1.00E00
protein import into nucleus (GO:0006606)	36	0	.79	-	 < 0.01	1.00E00
organic hydroxy compound biosynthetic process (GO:1901617)	42	0	.93	-	 < 0.01	1.00E00
sensory system development (GO:0048880)	31	0	.68	-	 < 0.01	1.00E00
G2/M transition of mitotic cell cycle (GO:0000086)	3	0	.07	-	 < 0.01	1.00E00
negative regulation of cell motility (GO:2000146)	10	0	.22	-	 < 0.01	1.00E00
G1/S transition of mitotic cell cycle (GO:0000082)	18	0	.40	-	 < 0.01	1.00E00
regulation of wound healing (GO:0061041)	6	0	.13	-	 < 0.01	1.00E00
miRNA processing (GO:0035196)	12	0	.26	-	 < 0.01	1.00E00
amino sugar catabolic process (GO:0046348)	3	0	.07	-	 < 0.01	1.00E00
protein K48-linked deubiquitination (GO:0071108)	3	0	.07	-	 < 0.01	1.00E00
regulatory ncRNA-mediated post-transcriptional gene silencing (GO:0035194)	9	0	.20	-	 < 0.01	1.00E00
adaptive immune response (GO:0002250)	8	0	.18	-	 < 0.01	1.00E00
DNA conformation change (GO:0071103)	15	0	.33	-	 < 0.01	1.00E00
spermatid differentiation (GO:0048515)	4	0	.09	-	 < 0.01	1.00E00
blood vessel morphogenesis (GO:0048514)	36	0	.79	-	 < 0.01	1.00E00
nucleobase-containing compound transport (GO:0015931)	57	0	1.26	-	 < 0.01	6.39E-01
rhythmic process (GO:0048511)	23	0	.51	-	 < 0.01	1.00E00
alpha-amino acid biosynthetic process (GO:1901607)	23	0	.51	-	 < 0.01	1.00E00
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	22	0	.48	-	 < 0.01	1.00E00
multicellular organismal-level homeostasis (GO:0048871)	12	0	.26	-	 < 0.01	1.00E00
alpha-amino acid metabolic process (GO:1901605)	73	0	1.61	-	 < 0.01	4.13E-01
DNA damage checkpoint signaling (GO:0000077)	19	0	.42	-	 < 0.01	1.00E00
DNA replication checkpoint signaling (GO:0000076)	8	0	.18	-	 < 0.01	1.00E00
inflammatory response (GO:0006954)	20	0	.44	-	 < 0.01	1.00E00
mitotic sister chromatid segregation (GO:0000070)	37	0	.82	-	 < 0.01	1.00E00
hematopoietic progenitor cell differentiation (GO:0002244)	1	0	.02	-	 < 0.01	1.00E00
positive regulation of JNK cascade (GO:0046330)	8	0	.18	-	 < 0.01	1.00E00
response to cytokine (GO:0034097)	52	0	1.15	-	 < 0.01	6.32E-01
stem cell development (GO:0048864)	29	0	.64	-	 < 0.01	1.00E00
syncytium formation (GO:0006949)	3	0	.07	-	 < 0.01	1.00E00
stem cell differentiation (GO:0048863)	29	0	.64	-	 < 0.01	1.00E00
response to molecule of bacterial origin (GO:0002237)	14	0	.31	-	 < 0.01	1.00E00
regulation of JNK cascade (GO:0046328)	12	0	.26	-	 < 0.01	1.00E00
negative regulation of programmed cell death (GO:0043069)	51	0	1.12	-	 < 0.01	6.30E-01
negative regulation of apoptotic process (GO:0043066)	50	0	1.10	-	 < 0.01	6.30E-01
sterol transport (GO:0015918)	16	0	.35	-	 < 0.01	1.00E00
phospholipid transport (GO:0015914)	30	0	.66	-	 < 0.01	1.00E00
regulation of muscle contraction (GO:0006937)	9	0	.20	-	 < 0.01	1.00E00
chemotaxis (GO:0006935)	35	0	.77	-	 < 0.01	1.00E00
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	3	0	.07	-	 < 0.01	1.00E00
regulation of cysteine-type endopeptidase activity (GO:2000116)	20	0	.44	-	 < 0.01	1.00E00
ribosomal subunit export from nucleus (GO:0000054)	8	0	.18	-	 < 0.01	1.00E00
pyrimidine-containing compound metabolic process (GO:0072527)	24	0	.53	-	 < 0.01	1.00E00
pyridine-containing compound metabolic process (GO:0072524)	31	0	.68	-	 < 0.01	1.00E00
endoplasmic reticulum unfolded protein response (GO:0030968)	18	0	.40	-	 < 0.01	1.00E00
toll-like receptor signaling pathway (GO:0002224)	4	0	.09	-	 < 0.01	1.00E00
pattern recognition receptor signaling pathway (GO:0002221)	12	0	.26	-	 < 0.01	1.00E00
long-chain fatty acid transport (GO:0015909)	4	0	.09	-	 < 0.01	1.00E00
fatty acid transport (GO:0015908)	19	0	.42	-	 < 0.01	1.00E00
transition metal ion transport (GO:0000041)	36	0	.79	-	 < 0.01	1.00E00
activation of innate immune response (GO:0002218)	13	0	.29	-	 < 0.01	1.00E00
negative regulation of peptidase activity (GO:0010466)	22	0	.48	-	 < 0.01	1.00E00
centrosome duplication (GO:0051298)	10	0	.22	-	 < 0.01	1.00E00
male sex differentiation (GO:0046661)	1	0	.02	-	 < 0.01	1.00E00
protein localization to Golgi apparatus (GO:0034067)	9	0	.20	-	 < 0.01	1.00E00
inner ear development (GO:0048839)	2	0	.04	-	 < 0.01	1.00E00
establishment of spindle orientation (GO:0051294)	10	0	.22	-	 < 0.01	1.00E00
cell-cell junction organization (GO:0045216)	41	0	.90	-	 < 0.01	1.00E00
establishment of spindle localization (GO:0051293)	17	0	.37	-	 < 0.01	1.00E00
sarcomere organization (GO:0045214)	15	0	.33	-	 < 0.01	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	12	0	.26	-	 < 0.01	1.00E00
phagocytosis, engulfment (GO:0006911)	7	0	.15	-	 < 0.01	1.00E00
pyridine nucleotide metabolic process (GO:0019362)	30	0	.66	-	 < 0.01	1.00E00
protein N-linked glycosylation via asparagine (GO:0018279)	10	0	.22	-	 < 0.01	1.00E00
cellular response to organonitrogen compound (GO:0071417)	46	0	1.01	-	 < 0.01	6.27E-01
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	2	0	.04	-	 < 0.01	1.00E00
somatic diversification of immune receptors (GO:0002200)	2	0	.04	-	 < 0.01	1.00E00
lymphocyte proliferation (GO:0046651)	1	0	.02	-	 < 0.01	1.00E00
regulation of macrophage activation (GO:0043030)	1	0	.02	-	 < 0.01	1.00E00
cellular response to BMP stimulus (GO:0071773)	15	0	.33	-	 < 0.01	1.00E00
response to BMP (GO:0071772)	15	0	.33	-	 < 0.01	1.00E00
triglyceride homeostasis (GO:0070328)	5	0	.11	-	 < 0.01	1.00E00
phagocytosis (GO:0006909)	19	0	.42	-	 < 0.01	1.00E00
ribosomal large subunit assembly (GO:0000027)	8	0	.18	-	 < 0.01	1.00E00
spliceosomal snRNP assembly (GO:0000387)	14	0	.31	-	 < 0.01	1.00E00
vesicle targeting (GO:0006903)	8	0	.18	-	 < 0.01	1.00E00
alternative mRNA splicing, via spliceosome (GO:0000380)	6	0	.13	-	 < 0.01	1.00E00
lymphocyte activation (GO:0046649)	15	0	.33	-	 < 0.01	1.00E00
cellular response to organic cyclic compound (GO:0071407)	23	0	.51	-	 < 0.01	1.00E00
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	4	0	.09	-	 < 0.01	1.00E00
nuclear membrane organization (GO:0071763)	4	0	.09	-	 < 0.01	1.00E00
central nervous system neuron differentiation (GO:0021953)	5	0	.11	-	 < 0.01	1.00E00
dendrite morphogenesis (GO:0048813)	2	0	.04	-	 < 0.01	1.00E00
regulation of DNA recombination (GO:0000018)	6	0	.13	-	 < 0.01	1.00E00
granulocyte migration (GO:0097530)	3	0	.07	-	 < 0.01	1.00E00
anatomical structure homeostasis (GO:0060249)	4	0	.09	-	 < 0.01	1.00E00
camera-type eye development (GO:0043010)	24	0	.53	-	 < 0.01	1.00E00
telomere localization (GO:0034397)	1	0	.02	-	 < 0.01	1.00E00
protein depolymerization (GO:0051261)	23	0	.51	-	 < 0.01	1.00E00
myeloid leukocyte migration (GO:0097529)	3	0	.07	-	 < 0.01	1.00E00
regulation of leukocyte proliferation (GO:0070663)	5	0	.11	-	 < 0.01	1.00E00
synaptic vesicle exocytosis (GO:0016079)	21	0	.46	-	 < 0.01	1.00E00
leukocyte proliferation (GO:0070661)	1	0	.02	-	 < 0.01	1.00E00
motile cilium assembly (GO:0044458)	4	0	.09	-	 < 0.01	1.00E00
mitochondrial genome maintenance (GO:0000002)	6	0	.13	-	 < 0.01	1.00E00
snRNA metabolic process (GO:0016073)	26	0	.57	-	 < 0.01	1.00E00
rRNA metabolic process (GO:0016072)	90	0	1.98	-	 < 0.01	2.71E-01
centriole replication (GO:0007099)	9	0	.20	-	 < 0.01	1.00E00
centrosome cycle (GO:0007098)	18	0	.40	-	 < 0.01	1.00E00
nuclear migration (GO:0007097)	10	0	.22	-	 < 0.01	1.00E00
negative regulation of double-strand break repair (GO:2000780)	5	0	.11	-	 < 0.01	1.00E00
chordate embryonic development (GO:0043009)	23	0	.51	-	 < 0.01	1.00E00
mitotic G2 DNA damage checkpoint signaling (GO:0007095)	8	0	.18	-	 < 0.01	1.00E00
mitotic spindle assembly checkpoint signaling (GO:0007094)	9	0	.20	-	 < 0.01	1.00E00
regulation of mitotic spindle organization (GO:0060236)	2	0	.04	-	 < 0.01	1.00E00
mitotic cell cycle checkpoint signaling (GO:0007093)	25	0	.55	-	 < 0.01	1.00E00
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	2	0	.04	-	 < 0.01	1.00E00
protein polymerization (GO:0051258)	29	0	.64	-	 < 0.01	1.00E00
Golgi to plasma membrane protein transport (GO:0043001)	7	0	.15	-	 < 0.01	1.00E00
response to temperature stimulus (GO:0009266)	12	0	.26	-	 < 0.01	1.00E00
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	8	0	.18	-	 < 0.01	1.00E00
regulation of exocytosis (GO:0017157)	26	0	.57	-	 < 0.01	1.00E00
calcium-ion regulated exocytosis (GO:0017156)	16	0	.35	-	 < 0.01	1.00E00
positive regulation of lymphocyte activation (GO:0051251)	5	0	.11	-	 < 0.01	1.00E00
purine nucleoside metabolic process (GO:0042278)	7	0	.15	-	 < 0.01	1.00E00
negative regulation of lymphocyte activation (GO:0051250)	5	0	.11	-	 < 0.01	1.00E00
ribosomal small subunit biogenesis (GO:0042274)	44	0	.97	-	 < 0.01	1.00E00
ribosomal large subunit biogenesis (GO:0042273)	40	0	.88	-	 < 0.01	1.00E00
regulation of double-strand break repair (GO:2000779)	7	0	.15	-	 < 0.01	1.00E00
cardiac muscle cell action potential involved in contraction (GO:0086002)	5	0	.11	-	 < 0.01	1.00E00
cell-cell fusion (GO:0140253)	3	0	.07	-	 < 0.01	1.00E00
immunoglobulin mediated immune response (GO:0016064)	2	0	.04	-	 < 0.01	1.00E00
regulation of mitotic nuclear division (GO:0007088)	25	0	.55	-	 < 0.01	1.00E00
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	16	0	.35	-	 < 0.01	1.00E00
leukocyte differentiation (GO:0002521)	16	0	.35	-	 < 0.01	1.00E00
immune system development (GO:0002520)	5	0	.11	-	 < 0.01	1.00E00
forebrain development (GO:0030900)	11	0	.24	-	 < 0.01	1.00E00
regulation of lymphocyte activation (GO:0051249)	10	0	.22	-	 < 0.01	1.00E00
mitotic metaphase chromosome alignment (GO:0007080)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of translation (GO:0017148)	14	0	.31	-	 < 0.01	1.00E00
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	2	0	.04	-	 < 0.01	1.00E00
positive regulation of TORC1 signaling (GO:1904263)	12	0	.26	-	 < 0.01	1.00E00
negative regulation of TORC1 signaling (GO:1904262)	6	0	.13	-	 < 0.01	1.00E00
glucan biosynthetic process (GO:0009250)	2	0	.04	-	 < 0.01	1.00E00
protein modification by small protein removal (GO:0070646)	64	0	1.41	-	 < 0.01	4.06E-01
hexose biosynthetic process (GO:0019319)	8	0	.18	-	 < 0.01	1.00E00
hexose metabolic process (GO:0019318)	23	0	.51	-	 < 0.01	1.00E00
organic acid catabolic process (GO:0016054)	68	0	1.50	-	 < 0.01	4.08E-01
mannosylation (GO:0097502)	8	0	.18	-	 < 0.01	1.00E00
organic acid biosynthetic process (GO:0016053)	55	0	1.21	-	 < 0.01	6.35E-01
regulation of lymphocyte migration (GO:2000401)	3	0	.07	-	 < 0.01	1.00E00
carbohydrate catabolic process (GO:0016052)	28	0	.62	-	 < 0.01	1.00E00
carbohydrate biosynthetic process (GO:0016051)	19	0	.42	-	 < 0.01	1.00E00
mitotic chromosome condensation (GO:0007076)	7	0	.15	-	 < 0.01	1.00E00
regulation of centrosome cycle (GO:0046605)	6	0	.13	-	 < 0.01	1.00E00
establishment of RNA localization (GO:0051236)	37	0	.82	-	 < 0.01	1.00E00
spindle elongation (GO:0051231)	7	0	.15	-	 < 0.01	1.00E00
ribosome biogenesis (GO:0042254)	121	0	2.67	-	 < 0.01	1.18E-01
actin polymerization or depolymerization (GO:0008154)	29	0	.64	-	 < 0.01	1.00E00
cell cycle DNA replication (GO:0044786)	12	0	.26	-	 < 0.01	1.00E00
lipid catabolic process (GO:0016042)	67	0	1.48	-	 < 0.01	4.07E-01
metaphase/anaphase transition of cell cycle (GO:0044784)	2	0	.04	-	 < 0.01	1.00E00
septin cytoskeleton organization (GO:0032185)	3	0	.07	-	 < 0.01	1.00E00
peptidyl-tyrosine modification (GO:0018212)	9	0	.20	-	 < 0.01	1.00E00
spindle assembly (GO:0051225)	24	0	.53	-	 < 0.01	1.00E00
regeneration (GO:0031099)	2	0	.04	-	 < 0.01	1.00E00
regulation of protein transport (GO:0051223)	13	0	.29	-	 < 0.01	1.00E00
cell activation (GO:0001775)	27	0	.59	-	 < 0.01	1.00E00
positive regulation of protein transport (GO:0051222)	4	0	.09	-	 < 0.01	1.00E00
detection of chemical stimulus (GO:0009593)	5	0	.11	-	 < 0.01	1.00E00
tissue regeneration (GO:0042246)	2	0	.04	-	 < 0.01	1.00E00
plasma membrane phospholipid scrambling (GO:0017121)	5	0	.11	-	 < 0.01	1.00E00
positive regulation of proteolysis (GO:0045862)	40	0	.88	-	 < 0.01	1.00E00
negative regulation of proteolysis (GO:0045861)	27	0	.59	-	 < 0.01	1.00E00
nuclear DNA replication (GO:0033260)	12	0	.26	-	 < 0.01	1.00E00
mitotic DNA integrity checkpoint signaling (GO:0044774)	13	0	.29	-	 < 0.01	1.00E00
peptidyl-serine modification (GO:0018209)	74	0	1.63	-	 < 0.01	4.14E-01
mitotic DNA damage checkpoint signaling (GO:0044773)	13	0	.29	-	 < 0.01	1.00E00
mitotic cell cycle phase transition (GO:0044772)	33	0	.73	-	 < 0.01	1.00E00
cell cycle phase transition (GO:0044770)	33	0	.73	-	 < 0.01	1.00E00
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	7	0	.15	-	 < 0.01	1.00E00
membrane assembly (GO:0071709)	12	0	.26	-	 < 0.01	1.00E00
mitotic spindle organization (GO:0007052)	26	0	.57	-	 < 0.01	1.00E00
spindle organization (GO:0007051)	40	0	.88	-	 < 0.01	1.00E00
cartilage development (GO:0051216)	10	0	.22	-	 < 0.01	1.00E00
nucleotide-sugar metabolic process (GO:0009225)	7	0	.15	-	 < 0.01	1.00E00
neuron migration (GO:0001764)	10	0	.22	-	 < 0.01	1.00E00
morphogenesis of a branching structure (GO:0001763)	1	0	.02	-	 < 0.01	1.00E00
glucose homeostasis (GO:0042593)	9	0	.20	-	 < 0.01	1.00E00
protein localization to endoplasmic reticulum (GO:0070972)	23	0	.51	-	 < 0.01	1.00E00
aerobic electron transport chain (GO:0019646)	4	0	.09	-	 < 0.01	1.00E00
cell-substrate junction assembly (GO:0007044)	1	0	.02	-	 < 0.01	1.00E00
cell-cell junction assembly (GO:0007043)	35	0	.77	-	 < 0.01	1.00E00
lysosomal transport (GO:0007041)	19	0	.42	-	 < 0.01	1.00E00
lysosome organization (GO:0007040)	14	0	.31	-	 < 0.01	1.00E00
protein insertion into membrane (GO:0051205)	4	0	.09	-	 < 0.01	1.00E00
neural crest cell migration (GO:0001755)	27	0	.59	-	 < 0.01	1.00E00
adherens junction organization (GO:0034332)	23	0	.51	-	 < 0.01	1.00E00
mitochondrial calcium ion homeostasis (GO:0051560)	10	0	.22	-	 < 0.01	1.00E00
cell junction organization (GO:0034330)	104	0	2.29	-	 < 0.01	1.77E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	9	0	.20	-	 < 0.01	1.00E00
positive regulation of mitotic nuclear division (GO:0045840)	10	0	.22	-	 < 0.01	1.00E00
ERAD pathway (GO:0036503)	35	0	.77	-	 < 0.01	1.00E00
response to reactive oxygen species (GO:0000302)	7	0	.15	-	 < 0.01	1.00E00
mononuclear cell differentiation (GO:1903131)	11	0	.24	-	 < 0.01	1.00E00
protein localization to synapse (GO:0035418)	13	0	.29	-	 < 0.01	1.00E00
vacuolar acidification (GO:0007035)	9	0	.20	-	 < 0.01	1.00E00
regulation of neurotransmitter secretion (GO:0046928)	14	0	.31	-	 < 0.01	1.00E00
endosome organization (GO:0007032)	13	0	.29	-	 < 0.01	1.00E00
positive regulation of response to biotic stimulus (GO:0002833)	21	0	.46	-	 < 0.01	1.00E00
peroxisome organization (GO:0007031)	20	0	.44	-	 < 0.01	1.00E00
Golgi organization (GO:0007030)	40	0	.88	-	 < 0.01	1.00E00
regulation of phosphoprotein phosphatase activity (GO:0043666)	5	0	.11	-	 < 0.01	1.00E00
cell junction assembly (GO:0034329)	58	0	1.28	-	 < 0.01	6.40E-01
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	1	0	.02	-	 < 0.01	1.00E00
purine ribonucleoside triphosphate metabolic process (GO:0009205)	19	0	.42	-	 < 0.01	1.00E00
fertilization (GO:0009566)	5	0	.11	-	 < 0.01	1.00E00
negative regulation of mitotic nuclear division (GO:0045839)	9	0	.20	-	 < 0.01	1.00E00
ribonucleoside triphosphate biosynthetic process (GO:0009201)	3	0	.07	-	 < 0.01	1.00E00
translesion synthesis (GO:0019985)	10	0	.22	-	 < 0.01	1.00E00
pattern specification process (GO:0007389)	57	0	1.26	-	 < 0.01	6.39E-01
protein transmembrane import into intracellular organelle (GO:0044743)	21	0	.46	-	 < 0.01	1.00E00
activation of protein kinase activity (GO:0032147)	5	0	.11	-	 < 0.01	1.00E00
microtubule nucleation (GO:0007020)	16	0	.35	-	 < 0.01	1.00E00
positive regulation of adaptive immune response (GO:0002821)	1	0	.02	-	 < 0.01	1.00E00
mismatch repair (GO:0006298)	10	0	.22	-	 < 0.01	1.00E00
Arp2/3 complex-mediated actin nucleation (GO:0034314)	12	0	.26	-	 < 0.01	1.00E00
pre-miRNA processing (GO:0031054)	6	0	.13	-	 < 0.01	1.00E00
primary miRNA processing (GO:0031053)	2	0	.04	-	 < 0.01	1.00E00
dendrite development (GO:0016358)	8	0	.18	-	 < 0.01	1.00E00
microtubule depolymerization (GO:0007019)	10	0	.22	-	 < 0.01	1.00E00
actin filament organization (GO:0007015)	125	0	2.75	-	 < 0.01	1.19E-01
dicarboxylic acid metabolic process (GO:0043648)	12	0	.26	-	 < 0.01	1.00E00
response to lipopolysaccharide (GO:0032496)	14	0	.31	-	 < 0.01	1.00E00
nucleotide-excision repair (GO:0006289)	18	0	.40	-	 < 0.01	1.00E00
membrane depolarization (GO:0051899)	21	0	.46	-	 < 0.01	1.00E00
base-excision repair (GO:0006284)	11	0	.24	-	 < 0.01	1.00E00
regulation of DNA repair (GO:0006282)	15	0	.33	-	 < 0.01	1.00E00
protein K48-linked ubiquitination (GO:0070936)	9	0	.20	-	 < 0.01	1.00E00
myelination (GO:0042552)	10	0	.22	-	 < 0.01	1.00E00
plasma membrane organization (GO:0007009)	24	0	.53	-	 < 0.01	1.00E00
gastrulation (GO:0007369)	13	0	.29	-	 < 0.01	1.00E00
inner mitochondrial membrane organization (GO:0007007)	11	0	.24	-	 < 0.01	1.00E00
mitochondrial membrane organization (GO:0007006)	14	0	.31	-	 < 0.01	1.00E00
determination of left/right symmetry (GO:0007368)	2	0	.04	-	 < 0.01	1.00E00
regulation of cilium assembly (GO:1902017)	5	0	.11	-	 < 0.01	1.00E00
telomere maintenance via telomerase (GO:0007004)	6	0	.13	-	 < 0.01	1.00E00
vesicle targeting, to, from or within Golgi (GO:0048199)	4	0	.09	-	 < 0.01	1.00E00
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	3	0	.07	-	 < 0.01	1.00E00
negative regulation of locomotion (GO:0040013)	10	0	.22	-	 < 0.01	1.00E00
positive regulation of type I interferon production (GO:0032481)	2	0	.04	-	 < 0.01	1.00E00
locomotion (GO:0040011)	35	0	.77	-	 < 0.01	1.00E00
nucleobase-containing small molecule catabolic process (GO:0034656)	8	0	.18	-	 < 0.01	1.00E00
positive regulation of endocytosis (GO:0045807)	2	0	.04	-	 < 0.01	1.00E00
negative regulation of protein ubiquitination (GO:0031397)	6	0	.13	-	 < 0.01	1.00E00
negative regulation of endocytosis (GO:0045806)	4	0	.09	-	 < 0.01	1.00E00
actomyosin structure organization (GO:0031032)	50	0	1.10	-	 < 0.01	6.30E-01
DNA strand elongation involved in DNA replication (GO:0006271)	12	0	.26	-	 < 0.01	1.00E00
DNA replication initiation (GO:0006270)	15	0	.33	-	 < 0.01	1.00E00
tumor necrosis factor-mediated signaling pathway (GO:0033209)	4	0	.09	-	 < 0.01	1.00E00
regulation of insulin secretion (GO:0050796)	5	0	.11	-	 < 0.01	1.00E00
regulation of plasma membrane bounded cell projection organization (GO:0120035)	62	0	1.37	-	 < 0.01	6.48E-01
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	23	0	.51	-	 < 0.01	1.00E00
intraciliary transport involved in cilium assembly (GO:0035735)	3	0	.07	-	 < 0.01	1.00E00
cell fate specification (GO:0001708)	28	0	.62	-	 < 0.01	1.00E00
mesoderm formation (GO:0001707)	7	0	.15	-	 < 0.01	1.00E00
DNA unwinding involved in DNA replication (GO:0006268)	7	0	.15	-	 < 0.01	1.00E00
endoderm formation (GO:0001706)	7	0	.15	-	 < 0.01	1.00E00
establishment of mitotic spindle localization (GO:0040001)	13	0	.29	-	 < 0.01	1.00E00
formation of primary germ layer (GO:0001704)	13	0	.29	-	 < 0.01	1.00E00
microtubule organizing center organization (GO:0031023)	22	0	.48	-	 < 0.01	1.00E00
regulatory ncRNA processing (GO:0070918)	20	0	.44	-	 < 0.01	1.00E00
DNA-templated DNA replication (GO:0006261)	65	0	1.43	-	 < 0.01	4.06E-01
DNA replication (GO:0006260)	71	0	1.56	-	 < 0.01	4.10E-01
regulation of receptor signaling pathway via STAT (GO:1904892)	6	0	.13	-	 < 0.01	1.00E00
unsaturated fatty acid metabolic process (GO:0033559)	9	0	.20	-	 < 0.01	1.00E00
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	5	0	.11	-	 < 0.01	1.00E00
post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	0	.04	-	 < 0.01	1.00E00
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	4	0	.09	-	 < 0.01	1.00E00
sodium ion transmembrane transport (GO:0035725)	46	0	1.01	-	 < 0.01	6.27E-01
positive regulation of response to external stimulus (GO:0032103)	29	0	.64	-	 < 0.01	1.00E00
regulation of cytokinesis (GO:0032465)	5	0	.11	-	 < 0.01	1.00E00
intraciliary retrograde transport (GO:0035721)	6	0	.13	-	 < 0.01	1.00E00
carbohydrate derivative transport (GO:1901264)	23	0	.51	-	 < 0.01	1.00E00
amide transport (GO:0042886)	10	0	.22	-	 < 0.01	1.00E00
regulation of dendrite development (GO:0050773)	12	0	.26	-	 < 0.01	1.00E00
cyclic-nucleotide-mediated signaling (GO:0019935)	18	0	.40	-	 < 0.01	1.00E00
positive regulation of axonogenesis (GO:0050772)	7	0	.15	-	 < 0.01	1.00E00
mitochondrial RNA processing (GO:0000963)	7	0	.15	-	 < 0.01	1.00E00
regulation of TORC1 signaling (GO:1903432)	18	0	.40	-	 < 0.01	1.00E00
cGMP-mediated signaling (GO:0019934)	2	0	.04	-	 < 0.01	1.00E00
cAMP-mediated signaling (GO:0019933)	16	0	.35	-	 < 0.01	1.00E00
regulation of axonogenesis (GO:0050770)	14	0	.31	-	 < 0.01	1.00E00
binding of sperm to zona pellucida (GO:0007339)	1	0	.02	-	 < 0.01	1.00E00
bone mineralization (GO:0030282)	1	0	.02	-	 < 0.01	1.00E00
single fertilization (GO:0007338)	5	0	.11	-	 < 0.01	1.00E00
endocytic recycling (GO:0032456)	29	0	.64	-	 < 0.01	1.00E00
regulation of neuronal synaptic plasticity (GO:0048168)	8	0	.18	-	 < 0.01	1.00E00
regulation of synaptic plasticity (GO:0048167)	24	0	.53	-	 < 0.01	1.00E00
cellular response to unfolded protein (GO:0034620)	19	0	.42	-	 < 0.01	1.00E00
mitochondrial protein processing (GO:0034982)	4	0	.09	-	 < 0.01	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	13	0	.29	-	 < 0.01	1.00E00
intermembrane lipid transfer (GO:0120009)	2	0	.04	-	 < 0.01	1.00E00
negative regulation of cAMP-mediated signaling (GO:0043951)	2	0	.04	-	 < 0.01	1.00E00
polyamine biosynthetic process (GO:0006596)	6	0	.13	-	 < 0.01	1.00E00
polyamine metabolic process (GO:0006595)	7	0	.15	-	 < 0.01	1.00E00
response to tumor necrosis factor (GO:0034612)	7	0	.15	-	 < 0.01	1.00E00
chromosome condensation (GO:0030261)	8	0	.18	-	 < 0.01	1.00E00
melanosome organization (GO:0032438)	5	0	.11	-	 < 0.01	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	15	0	.33	-	 < 0.01	1.00E00
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	4	0	.09	-	 < 0.01	1.00E00
regulation of cAMP-mediated signaling (GO:0043949)	2	0	.04	-	 < 0.01	1.00E00
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	22	0	.48	-	 < 0.01	1.00E00
positive regulation of defense response (GO:0031349)	19	0	.42	-	 < 0.01	1.00E00
cellular response to heat (GO:0034605)	5	0	.11	-	 < 0.01	1.00E00
catecholamine metabolic process (GO:0006584)	5	0	.11	-	 < 0.01	1.00E00
regulation of cell projection organization (GO:0031344)	63	0	1.39	-	 < 0.01	6.51E-01
pyrimidine nucleotide metabolic process (GO:0006220)	12	0	.26	-	 < 0.01	1.00E00
regulation of cell killing (GO:0031341)	2	0	.04	-	 < 0.01	1.00E00
positive regulation of DNA-templated transcription, elongation (GO:0032786)	10	0	.22	-	 < 0.01	1.00E00
intracellular protein transmembrane transport (GO:0065002)	17	0	.37	-	 < 0.01	1.00E00
regulation of DNA-templated transcription elongation (GO:0032784)	13	0	.29	-	 < 0.01	1.00E00
biogenic amine metabolic process (GO:0006576)	17	0	.37	-	 < 0.01	1.00E00
cellular modified amino acid metabolic process (GO:0006575)	47	0	1.04	-	 < 0.01	6.28E-01
negative regulation of protein-containing complex assembly (GO:0031333)	23	0	.51	-	 < 0.01	1.00E00
regulation of non-canonical NF-kappaB signal transduction (GO:1901222)	2	0	.04	-	 < 0.01	1.00E00
tyrosine metabolic process (GO:0006570)	6	0	.13	-	 < 0.01	1.00E00
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	10	0	.22	-	 < 0.01	1.00E00
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	14	0	.31	-	 < 0.01	1.00E00
non-canonical NF-kappaB signal transduction (GO:0038061)	2	0	.04	-	 < 0.01	1.00E00
carbohydrate homeostasis (GO:0033500)	9	0	.20	-	 < 0.01	1.00E00
lysosome localization (GO:0032418)	5	0	.11	-	 < 0.01	1.00E00
synaptic vesicle transport (GO:0048489)	9	0	.20	-	 < 0.01	1.00E00
regulation of monoatomic ion transmembrane transporter activity (GO:0032412)	40	0	.88	-	 < 0.01	1.00E00
positive regulation of transporter activity (GO:0032411)	12	0	.26	-	 < 0.01	1.00E00
pyrimidine nucleobase catabolic process (GO:0006208)	5	0	.11	-	 < 0.01	1.00E00
pyrimidine nucleobase metabolic process (GO:0006206)	9	0	.20	-	 < 0.01	1.00E00
negative regulation of inflammatory response (GO:0050728)	8	0	.18	-	 < 0.01	1.00E00
regulation of inflammatory response (GO:0050727)	9	0	.20	-	 < 0.01	1.00E00
myofibril assembly (GO:0030239)	25	0	.55	-	 < 0.01	1.00E00
actomyosin contractile ring assembly (GO:0000915)	4	0	.09	-	 < 0.01	1.00E00
leukocyte chemotaxis (GO:0030595)	3	0	.07	-	 < 0.01	1.00E00
neutrophil chemotaxis (GO:0030593)	3	0	.07	-	 < 0.01	1.00E00
regulation of transporter activity (GO:0032409)	42	0	.93	-	 < 0.01	1.00E00
oogenesis (GO:0048477)	7	0	.15	-	 < 0.01	1.00E00
secondary alcohol biosynthetic process (GO:1902653)	7	0	.15	-	 < 0.01	1.00E00
secondary alcohol metabolic process (GO:1902652)	17	0	.37	-	 < 0.01	1.00E00
execution phase of apoptosis (GO:0097194)	8	0	.18	-	 < 0.01	1.00E00
extrinsic apoptotic signaling pathway (GO:0097191)	12	0	.26	-	 < 0.01	1.00E00
positive regulation of protein secretion (GO:0050714)	1	0	.02	-	 < 0.01	1.00E00
poly(A)+ mRNA export from nucleus (GO:0016973)	11	0	.24	-	 < 0.01	1.00E00
feeding behavior (GO:0007631)	4	0	.09	-	 < 0.01	1.00E00
amelogenesis (GO:0097186)	2	0	.04	-	 < 0.01	1.00E00
lipopolysaccharide-mediated signaling pathway (GO:0031663)	1	0	.02	-	 < 0.01	1.00E00
regulation of protein secretion (GO:0050708)	7	0	.15	-	 < 0.01	1.00E00
erythrocyte differentiation (GO:0030218)	5	0	.11	-	 < 0.01	1.00E00
T cell differentiation (GO:0030217)	6	0	.13	-	 < 0.01	1.00E00
Rac protein signal transduction (GO:0016601)	3	0	.07	-	 < 0.01	1.00E00
circadian rhythm (GO:0007623)	22	0	.48	-	 < 0.01	1.00E00
receptor-mediated endocytosis (GO:0006898)	28	0	.62	-	 < 0.01	1.00E00
glutamate metabolic process (GO:0006536)	2	0	.04	-	 < 0.01	1.00E00
Golgi to vacuole transport (GO:0006896)	5	0	.11	-	 < 0.01	1.00E00
Golgi to endosome transport (GO:0006895)	1	0	.02	-	 < 0.01	1.00E00
Golgi to plasma membrane transport (GO:0006893)	23	0	.51	-	 < 0.01	1.00E00
aspartate metabolic process (GO:0006531)	1	0	.02	-	 < 0.01	1.00E00
post-Golgi vesicle-mediated transport (GO:0006892)	34	0	.75	-	 < 0.01	1.00E00
intra-Golgi vesicle-mediated transport (GO:0006891)	20	0	.44	-	 < 0.01	1.00E00
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	18	0	.40	-	 < 0.01	1.00E00
glycosaminoglycan metabolic process (GO:0030203)	21	0	.46	-	 < 0.01	1.00E00
cytoplasmic translational initiation (GO:0002183)	9	0	.20	-	 < 0.01	1.00E00
cytoplasmic translation (GO:0002181)	28	0	.62	-	 < 0.01	1.00E00
cellular response to lipid (GO:0071396)	23	0	.51	-	 < 0.01	1.00E00
behavior (GO:0007610)	7	0	.15	-	 < 0.01	1.00E00
exocytosis (GO:0006887)	79	0	1.74	-	 < 0.01	4.24E-01
arginine metabolic process (GO:0006525)	11	0	.24	-	 < 0.01	1.00E00
regulation of protein stability (GO:0031647)	15	0	.33	-	 < 0.01	1.00E00
regulation of pH (GO:0006885)	27	0	.59	-	 < 0.01	1.00E00
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	15	0	.33	-	 < 0.01	1.00E00
regulation of hemopoiesis (GO:1903706)	7	0	.15	-	 < 0.01	1.00E00
sensory perception of chemical stimulus (GO:0007606)	4	0	.09	-	 < 0.01	1.00E00
sensory perception of sound (GO:0007605)	11	0	.24	-	 < 0.01	1.00E00
cellular response to steroid hormone stimulus (GO:0071383)	6	0	.13	-	 < 0.01	1.00E00
visual perception (GO:0007601)	20	0	.44	-	 < 0.01	1.00E00
mitotic DNA replication initiation (GO:1902975)	6	0	.13	-	 < 0.01	1.00E00
sensory perception (GO:0007600)	41	0	.90	-	 < 0.01	1.00E00
intracellular iron ion homeostasis (GO:0006879)	5	0	.11	-	 < 0.01	1.00E00
organic hydroxy compound transport (GO:0015850)	26	0	.57	-	 < 0.01	1.00E00
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	5	0	.11	-	 < 0.01	1.00E00
zymogen activation (GO:0031638)	6	0	.13	-	 < 0.01	1.00E00
regulation of cell junction assembly (GO:1901888)	15	0	.33	-	 < 0.01	1.00E00
protein monoubiquitination (GO:0006513)	5	0	.11	-	 < 0.01	1.00E00
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	23	0	.51	-	 < 0.01	1.00E00
intracellular calcium ion homeostasis (GO:0006874)	53	0	1.17	-	 < 0.01	6.33E-01
regulation of membrane depolarization (GO:0003254)	5	0	.11	-	 < 0.01	1.00E00
intracellular monoatomic ion homeostasis (GO:0006873)	106	0	2.34	-	 < 0.01	1.78E-01
negative regulation of protein depolymerization (GO:1901880)	23	0	.51	-	 < 0.01	1.00E00
mitotic DNA replication (GO:1902969)	9	0	.20	-	 < 0.01	1.00E00
cellular response to peptide hormone stimulus (GO:0071375)	25	0	.55	-	 < 0.01	1.00E00
proton transmembrane transport (GO:1902600)	13	0	.29	-	 < 0.01	1.00E00
cell fate commitment (GO:0045165)	58	0	1.28	-	 < 0.01	6.40E-01
lipid transport (GO:0006869)	80	0	1.76	-	 < 0.01	4.26E-01
regulation of protein depolymerization (GO:1901879)	28	0	.62	-	 < 0.01	1.00E00
receptor internalization (GO:0031623)	12	0	.26	-	 < 0.01	1.00E00
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	5	0	.11	-	 < 0.01	1.00E00
protein sumoylation (GO:0016925)	11	0	.24	-	 < 0.01	1.00E00
peptide transport (GO:0015833)	5	0	.11	-	 < 0.01	1.00E00
oligopeptide transport (GO:0006857)	2	0	.04	-	 < 0.01	1.00E00
tissue remodeling (GO:0048771)	1	0	.02	-	 < 0.01	1.00E00
regulation of B cell proliferation (GO:0030888)	3	0	.07	-	 < 0.01	1.00E00
regulation of centriole replication (GO:0046599)	4	0	.09	-	 < 0.01	1.00E00
intracellular receptor signaling pathway (GO:0030522)	13	0	.29	-	 < 0.01	1.00E00
cellular response to tumor necrosis factor (GO:0071356)	7	0	.15	-	 < 0.01	1.00E00
homologous chromosome segregation (GO:0045143)	7	0	.15	-	 < 0.01	1.00E00
mesenchymal cell differentiation (GO:0048762)	31	0	.68	-	 < 0.01	1.00E00
leucine transport (GO:0015820)	1	0	.02	-	 < 0.01	1.00E00
tricarboxylic acid transport (GO:0006842)	4	0	.09	-	 < 0.01	1.00E00
regulation of system process (GO:0044057)	37	0	.82	-	 < 0.01	1.00E00
intracellular steroid hormone receptor signaling pathway (GO:0030518)	2	0	.04	-	 < 0.01	1.00E00
cellular response to cytokine stimulus (GO:0071345)	45	0	.99	-	 < 0.01	6.27E-01
regulation of lipase activity (GO:0060191)	1	0	.02	-	 < 0.01	1.00E00
glycine transport (GO:0015816)	3	0	.07	-	 < 0.01	1.00E00
meiotic chromosome segregation (GO:0045132)	11	0	.24	-	 < 0.01	1.00E00
inner dynein arm assembly (GO:0036159)	4	0	.09	-	 < 0.01	1.00E00
neurotransmitter transport (GO:0006836)	36	0	.79	-	 < 0.01	1.00E00
water transport (GO:0006833)	7	0	.15	-	 < 0.01	1.00E00
BMP signaling pathway (GO:0030509)	14	0	.31	-	 < 0.01	1.00E00
glucan metabolic process (GO:0044042)	6	0	.13	-	 < 0.01	1.00E00
cortical actin cytoskeleton organization (GO:0030866)	13	0	.29	-	 < 0.01	1.00E00
cortical cytoskeleton organization (GO:0030865)	20	0	.44	-	 < 0.01	1.00E00
signal release from synapse (GO:0099643)	33	0	.73	-	 < 0.01	1.00E00
peptidyl-amino acid modification (GO:0018193)	189	0	4.16	-	 < 0.01	2.34E-02
neutral amino acid transport (GO:0015804)	20	0	.44	-	 < 0.01	1.00E00
branched-chain amino acid transport (GO:0015803)	1	0	.02	-	 < 0.01	1.00E00
regulation of bone resorption (GO:0045124)	3	0	.07	-	 < 0.01	1.00E00
basic amino acid transport (GO:0015802)	2	0	.04	-	 < 0.01	1.00E00
iron ion transport (GO:0006826)	15	0	.33	-	 < 0.01	1.00E00
regulation of epithelial cell differentiation (GO:0030856)	7	0	.15	-	 < 0.01	1.00E00
epithelial cell differentiation (GO:0030855)	18	0	.40	-	 < 0.01	1.00E00
glial cell differentiation (GO:0010001)	14	0	.31	-	 < 0.01	1.00E00
cardiac muscle tissue development (GO:0048738)	14	0	.31	-	 < 0.01	1.00E00
protein neddylation (GO:0045116)	7	0	.15	-	 < 0.01	1.00E00
phosphate ion transport (GO:0006817)	9	0	.20	-	 < 0.01	1.00E00
sodium ion transport (GO:0006814)	51	0	1.12	-	 < 0.01	6.30E-01
striated muscle tissue development (GO:0014706)	14	0	.31	-	 < 0.01	1.00E00
protein localization to cytoskeleton (GO:0044380)	9	0	.20	-	 < 0.01	1.00E00
